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ABSTRACT 
Lutein could be a factor responsible for the low bioavailability and low bio conversion 
of p-carotene from dark green leafy vegetables. The high sensitivity of gas chromatography-
combustion interfaced-isotope ratio mass spectrometry (GC-C-IRMS) and the availability of 
highly-enriched ^C-Iabeled tracer doses of P-carotene and lutein make it possible to 
administer p-carotene and lutein at levels typical of dietary intake and to follow the fate of 
these carotenoids after their administration. Using this approach, we compared in female 
subjects the appearance of ^C-P-carotene and its cleavage product, ^C-retinol in the plasma 
after subjects ingested 1 mg of ^C-P-carotene with or without 3 mg of ^C-lutein. Women (n 
= 7) each ingested both the single dose of ^C-P-carotene and the combined dose of ^C-P-
carotene and ^C-lutein in random order. Blood samples were collected at selected intervals 
until 16 h post dosing. Additional blood samples were collected at selected hours until 528 h 
post dosing. Lutein, p-carotene and retinol were extracted from plasma and purified by using 
HPLC. Retinol samples were directly analyzed by using GC-C-IRMS; lutein and P-carotene 
were derivatized to thermally stable compounds and the derivatives were analyzed by using 
GC-C-IRMS. The appearance of ^C-P-carotene in the plasma was not different after the two 
doses; nor was the appearance of ^C-retinol in the plasma. The ratio of 0-96 h area under 
the concentration vs. time curve (AUC) for ^C-retinol to 0-528 h AUC for ^C-P-carotene 
was used as an index for conversion of ^C-p-carotene to ^C-retinol, and there was no 
difference in the ratios aAer the two doses. Plasma P-carotene concentration at baseline was 
negatively correlated with the 0-96 h AUC for ^C-retinol after the combined dose (r = -0.84, 
P = 0.02). Plasma lutein concentration at baseline was positively correlated with 0-528 h 
AUC for ^C-lutein (r = 0.82, P = 0.02), and positively correlated with 0-528 h AUC for ^C-
P-carotene aAer the ^C-p-carotene dose alone (r = 0.84, P = 0.02). The responses Aom the 
subjects aAer the two doses were highly variable. The interindividual coefficient of variance 
(CV) of 0-528 h AUC for ^C-P-carotene was 59% aAer the single dose and 36% aAer the 
combined dose. The CV of 0-96 h AUC for ^C-retinol was 64% aAer the single dose and 
53% aAer the combined dose. The CV of 0-528 h AUC for lutein was 44%. We concluded 
xi 
that a physiological dose of lutein does not inhibit the bioavailability of P-carotene and 
bioconversion of P-carotene to vitamin A in young women. This is the first study to 
investigate the interaction of P-carotene and lutein in humans using dose levels typical of 
dietary intake and a weight ratio of 3:1 that is common in vegetables. 
1 
GENERAL INTRODUCTION 
Thesis organization 
The dissertation is organized into three chapters, including a literature review, a 
manuscript prepared for submission to the American Journal of Clinical Nutrition, and 
general conclusions. The literature review consists of three parts. Part I reviews studies 
regarding to the interaction of P-carotene and lutein. Part II reviews application of stable 
isotope tracer methods in studies of P-carotene absorption and conversion. Part III reviews 
the recent molecular characterization of P-carotene cleavage enzymes. The manuscript 
presents an investigation of the effects of a physiological dose of lutein on the absorption and 
bioconversion of P-carotene in young women. The dissertation ends with general 
conclusions of the study. 
Literature Review 
Part I. Interactions of p-carotene and lutein 
Introduction 
In developing countries, provitamin A carotenoids in dark green leafy 
vegetables and yellow orange vegetables and fruits account for 70-90% of total vitamin A 
intake (WHO/UNICEF/IVACG Task Force 1997). Beta-carotene is abundant in dark green 
leafy vegetables but these vegetables are not effective in correcting vitamin A deficiency (de 
Pee et al 1995, Takyi 1999). The underlying mechanism may involve an inhibitory effect of 
lutein (P,e-carotene-3,3'-diol), a nonprovitamin A oxycarotenoid and structural analog of p-
carotene (Figure 1). Lutein is a characteristic matrix component in dark green leafy 
vegetables. The bioavailability of lutein from dark green leafy vegetables is considerably 
higher than that of P-carotene (van het Hof et al 1999a, van het Hof et al 1999b). Orange-
colored fruits and vegetables, which have little or no lutein, are more effective than dark 
green leafy vegetables in increasing serum concentrations of retinol and p-carotene in 
children (de Pee e al 1999, van Lieshout et al 2001). A high lutein content could adversely 
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affect the bioavailability of P-carotene in spinach and other dark green leafy vegetables by 
having a competitive or antagonistic effect on the intestinal absorption of P-carotene (Kostic 
et al 1995, van den Berg and van Vliet 1998), and/or by inhibiting the cleavage of P-carotene 
to vitamin A (van Vliet et al 1996a). 
The growing interest in mechanisms of lutein and P-carotene interaction is also 
generated from the interest in the putative health benefits of lutein. Consumption of lutein 
and zeaxanthin rich vegetables is negatively correlated with deterioration of the retina in the 
form of age-related macular degeneration (AMD) (Snodderly 1995). Epidemiological data 
from the Los Angeles Atherosclerosis Study have shown that increased dietary intake of 
lutein is protective against the development of early atherosclerosis (Dwyer et al 2001). 
Studies regarding to interaction of lutein and P-carotene, and interaction of other 
carotenoids, were reviewed a few years ago (van den Berg 1998, White and Paetau 1998, van 
den Berg 1999). 
In vitro studies 
In an in vitro measurement of P-carotene cleavage activity, rat and hamster intestinal 
homogenate were prepared. The 9,000 x g supernatant from the homogenate was used as the 
source of P-carotene cleavage enzyme. Addition of 9 ng of lutein to an incubation of 3 pg P-
carotene and the cleavage enzyme reduced retinal formation (van Vliet et al 1995a). 
Interaction of rabbit small intestine mucosa p-carotene cleavage enzyme and lutein showed 
that lutein competitively inhibited the p-carotene cleavage reaction (Ershov et al 1993). 
These studies seem to suggest that lutein inhibits the cleavage of p-carotene by inhibiting the 
enzymatic activity of p-carotene cleavage enzyme. However, another incubation study using 
9,000 x g supernatant prepared from rat intestine as the enzyme source did not find inhibitory 
effect of lutein on P-carotene cleavage (Grolier et al 1997). 
Animal studies 
A series of studies carried in the late 40's and early 50's investigated the effects of 
lutein on the utilization of P-carotene in rats (Kemmerer et al 1947, Kelley and Day 1948, 
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Johnson and Baumann 1948, High and Day 1951). Relatively large amounts of lutein (2.5 to 
20 times the amount of P-carotene) impaired the utilization of P-carotene in rats, whereas 
small amounts of lutein seemed to promote the utilization of P-carotene. The deposition of 
vitamin A in the liver was significantly decreased in rats fed more lutein (at P-carotene:lutein 
ratios < 1) (High and Day 1951). Recent study from out lab showed inhibitory effects of 
lutein on p-carotene utilization in gerbils. Gerbils fed with a vitamin A-free diet 
supplemented with the leaves from a lutein-free (W2) mutant had 48% more 
vitamin A stores in the liver than those fed with a vitamin A-free diet supplemented with the 
leaves from a wild type of (Yan et al 2003). Therefore in general, animal data 
seem to support the conclusion that lutein inhibits the bioavailability and/or bioconversion of 
p-carotene when ingested at higher amounts. 
Human Studies 
Human studies used pharmacological doses of P-carotene and lutein to investigate 
their interactions and the results have been inconsistent. In one study (Kostic et al 1995), 8 
subjects were given a p-carotene dose and an equimolar mixture of p-carotene and lutein. 
The dose level was 0.5 pmol/kg body weight. Lutein reduced the area under the 
concentration vs. time curve (AUC) value for p-carotene in subjects who had higher AUC 
value when ingested P-carotene alone, but enhanced AUC value for p-carotene in subjects 
who had lower AUC value when ingested P-carotene alone. In another study, a combined 
dose of 15 mg P-carotene and 15 mg of lutein decreased AUC for P-carotene in the 
triacylglycerol-rich lipoprotein (TRL) Action, but had no effect on the AUC for retinyl esters 
in TRL (van de Berg and van Vliet 1998). This suggests that lutein negatively affected P-
carotene absorption when given simultaneously, but had no effect on P-carotene cleavage. 
The inhibitory effect of lutein was most marked when lutein was the predominant carotenoid 
(at a lutein to P-carotene ratio of 2:1) (van den Berg 1998). One possible reason why lutein 
may inhibit the absorption of P-carotene is the preferential incorporation of lutein into 
chylomicrons compared with P-carotene. Gartnet et al (1996) reported that there was a 
preferential increase in chylomicron levels of lutein and zeaxanthin compared with P-
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carotene in humans aAer ingestion of a single dose of Betatene, a natural carotenoid source 
which contains P-carotene 14-A)Id higher than lutein. More recently, Tyssandier et al (2002) 
reported that adding a second carotenoid Aom a vegetable source to a meal that provided a 
first carotenoid diminished the chylomicron response to the first carotenoid. Fibers in 
vegetables have more impact on P-carotene absorption than on lutein absorption 
(Castenmiller et al 1999). Lutein is more efficiently transferred to micelles than p-carotene 
in the duodenum in humans (Tyssandier et al 2003). 
In these studies, P-carotene and lutein were ingested in doses that greatly exceed 
effective (absorbed) doses typically derived Aom Auits and vegetables (Swanson et al 1996). 
High dose of P-carotene down-regulates the enzymatic activity of P-carotene cleavage 
enzyme (Brubacher and Weiser 1985, van Vliet et al 1995a). The equimolar doses of P-
carotene and lutein that were administered do not extrapolate to the disproportionate content 
of lutein in dark green leaves (Adewusi and Bradbury 1993, USDA-NCC 1998, van den Berg 
et al 1998). Therefore there is a need to use physiological doses, and a lutein to P-carotene 
ratio typically found in vegetables, to investigate the interaction of lutein and P-carotene in 
our normal dietary intake. 
Part I. Application of stable isotopic tracing methods 
in p-carotene absorption and conversion studies 
Introduction 
As the major vitamin A precursor in foods, P-carotene is a nutrient of importance. 
The absorption and bioconversion of P-carotene has been the subject of investigation for over 
50 years (Moore 1957). However, there is a lack of characterized animal models which 
resemble humans with respect to p-carotene metabolism, and a lack of appropriate 
methodological tools which can be applied to study p-carotene metabolism in humans at 
levels typical of daily dietary intake. Therefore there remains considerable uncertainty with 
regard to quantification of p-carotene absorption and bioconversion in humans. 
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Application of stable isotopic tracing methodology has been a fairly recent approach 
to the study of p-carotene metabolism in humans. Previous approaches involved radioactive 
forms of P-carotene. Beta-carotene labeled with either or ^H was employed in two earlier 
studies of p-carotene absorption and intestinal metabolism in a small number of surgical 
patients with catheterized thoracic lymph ducts (Goodman et al 1966; Blomstrand and 
Werner 1967). These studies indicated that p-carotene absorption efficiency is probably low 
to moderate and highly variable between individuals. 
A stable isotope tracer approach eliminates the exposure of humans to radiation and 
associated handling and disposal costs of radioactive materials (Dueker et al 1998b; Parker 
2000). Other advantages include simultaneous determination of tracer/tracee molar ratio (% 
enrichment), specific detection of analyte according to its mass and mass fragmentation 
profile and known chromatographic behavior (hyphenated GC and LC/MS systems), and 
potential for administration of several different tracers both simultaneously and repeatedly so 
that more information can be obtained from a single experiment. For study of P-carotene 
metabolism, a stable isotope tracer approach provides a specific benefit, which is the option 
to administer a small, physiological dose that is similar to the daily dietary intake. A 
physiological dose will not disrupt the endogenous pools of P-carotene and its vitamin A 
metabolites, nor down-regulate the activity of intestinal p,p'-carotene-monooxygenase 
(Dueker et al 1998b; Parker 2000). 
Until now, there have only been a few studies of P-carotene absorption and 
conversion in humans using stable isotope tracer approaches (Table 1). The doses were 
labeled with ^H and ^C. There were also two studies using ^C-P-carotene that was not 
considered as radioactive because of the very small dose (Dueker et al, 2000, Hickenbottom 
et al 2002). The doses ranged from 1 mg to 126 mg. Except for one study that used kale that 
was grown in a ^COi-enriched atmosphere as the source of P-carotene dose (Kelm et al 
2001), all the other studies used purified p-carotene as the dose. The results from these 
studies indicate that the absorption rate and conversion rate of p-carotene to vitamin A are 
low, and there is high individual and gender variability (Table 1). 
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Double tracer method for measuring p-carotene absorption and conversion 
The use of a double-tracer method makes it possible to directly compare the 
metabolism of an oral dose of labeled p-carotene with that of an approximately equimolar 
dose of labeled vitamin A. 
In one study (Lin et al 2000), 11 healthy women ingested 30 pmol hexadeuterated 
(Da) retinyl acetate orally, Allowed with 37 juimol De P-carotene aAer one week. The results 
showed that the mean absorption of De p-carotene was 3.3 ± 1.3% and the mean conversion 
ratio was 0.81 ± 0.34 mol of trideuterated (D3) retinol to 1 mol of De p-carotene. Only 6 of 
the 11 subjects had measurable plasma De p-carotene and D3 retinol. The mean absorption of 
De p-carotene in these 6 subjects was 6.1 ± 0.02% and their mean conversion ratio was 1.47 
± 0.49 mol of D3 retinol to 1 mol of De p-carotene. The remaining 5 subjects were low 
responders with < 0.01% absorption and a mean conversion ratio of 0.014 ± 0.004 mol D3 
retinol to 1 mol De P-carotene. The mean absorption value of P-carotene was lower than 
values previously published (9-22%). This difference could be due to the fact that in 
previously published studies, P-carotene was dissolved in oil or dissolved in oil and 
emulsified, whereas in the their study the doses were not solublized and emulsified. The 
plasma De retinol concentration increased promptly and peaked around 21 hours aAer dosing. 
The plasma D3 retinol concentration also increased promptly but peaked at around 10 hours 
aAer dosing with De p-carotene, and this delay suggested that the plasma D3 retinol might 
consist of D3 retinyl esters generated in enterocytes. A positive correlation was found 
between the AUCs for plasma D3 retinol and those for its parent De P-carotene, which 
suggested that intestinal absorption and release of both p-carotene and vitamin A might be 
controlled by the same or similar Actors. The authors concluded 1) there were no 
biochemical markers in their small group of subjects that were associated with low response; 
2) nutritional status, as reflected by baseline plasma P-carotene and retinol concentrations, 
did not predict a subject's propensity to utilize p-carotene for vitamin A; and 3) both 
absorption of p-carotene and conversion of p-carotene to vitamin A contributed to the 
variable plasma response to ingested p-carotene. 
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In another study with a similar study design (Hickenbottom et al 2002a), 11 healthy 
men were orally dosed with 30 pmol Dg retinyl acetate and then one week later with 37 p.mol 
Dg P-carotene. The results showed a mean absorption of2.235 ± 0.925% for all subjects, and 
a mean conversion ratio of 0.0296 ± 0.0108 mol retinol to 1 mol p-carotene. Only 6 of 11 
subjects were responders who had measurable plasma concentrations of Dg P-carotene and 
Da retinol. The mean absorption of Da P-carotene in these 6 subjects was 4.097 ± 1.208%, 
and the mean conversion ratio was 0.054 ± 0.0128 mol retinol to 1 mol P-carotene. Unlike 
the findings in the first study, the responder group had significantly lower baseline 
concentrations of both retinol and P-carotene. Similar to the first study, there was a strong 
correlation between the AUCs for plasma D3 retinol and those for its parent compound Dg P-
carotene. The authors also concluded that the low-responder trait was not due to a greater 
conversion of ingested P-carotene to vitamin A, because the low responders to Dg P-carotene 
also had low plasma D3 retinol response. This conclusion is different from that suggested by 
Kostic et al (1995). 
The third study used three tracer doses: 30 pmol Dg retinyl acetate, 30 jimol D& P-
carotene, and 0.27 pmol ^C-P-carotene (Hickenbottom et al 2002b). The Dg/D; ratio of the 
two retinols in the plasma was not constant during the absorption/distribution phase (3-11 h), 
ranging between a value of 3 and 16. However between 11 and 98 h postdosing the ratio was 
relatively constant with a mean value of 8.5 h. They suggested that a single sample taken 
between 11-98 h postdosing may provide a reliable estimation for the relative dose of the two 
forms of vitamin A. In their subject, 8.5 mol of p-carotene would provide a retinol activity 
equivalent to 1 mol of preformed vitamin A. On a mass base, 15.9 pg of P-carotene was 
equivalent to 1 pg of retinol. Cumulative 24-h stool and urine samples were collected for 
two weeks to 6How the absorption and excretion of ^C-P-carotene. According to 
accelerator mass spectrometry (AMS) analysis of ^C in the cumulative stool, 53% of the 
total administered P-carotene was absorbed. 
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Stable isotope reference method 
Tang et al (1997) developed a method that used flow-injection atmospheric pressure 
chemical ionization-mass spectrometry (FI/APCI-MS) to measure the plasma enrichment of 
P-carotene-dg (11, 11', 19, 19, 19, 19', 19', 19'-^Hg-P-carotene) in a subject orally 
supplemented with p-carotene-dg. They also investigated the kinetics of the metabolism of 
P-carotene-dg to retinol-d* by using gas chromatography-mass spectrometry with electron 
capture negative chemical ionization (GC/EC-NCI-MS) to measure the plasma enrichment of 
retinol-d* derivatives. By applying these methods the same research group studied the 
vitamin A equivalence of p-carotene in a woman (Tang et al 2000) and in a group of 22 
adults (Tang et al 2003). 
In the first study (Tang et al 2000), two dosage levels of P-carotene-dg (a 
pharmacological dose, 126.0 mg, and a physiological dose, 6.0 mg) were used 2.5 year apart 
in a female adult, and multiple blood samples were collected after each dose over a 21-day 
period. Retinyl acetate-dg (9.0 mg) was used as the vitamin A reference. Serum p-carotene 
concentrations did not change aAer the 6-mg P-carotene dose. However, serum P-carotene 
concentration was about three times the baseline level at 24 h aAer the 126-mg dose. The 
retinol-d* response in the circulation peaked at 24 hours aAer the P-carotene-dg dose with a 
higher percent enrichment aAer the pharmacological dose than the physiological dose. The 
retinol-ck formed Aom a 6-mg dose of P-carotene-dg was calculated to be equivalent to 1.6 
mg of retinol (conversion rate: 3.8:1), and the retinol-cL* formed Aom a 126-mg of P-
carotene-dg was equivalent to 2.3 mg of retinol (conversion rate: 55:1). These results 
indicate that the size of the dose affects the conversion rate of p-carotene to vitamin A, and a 
higher dose results in lower conversion. 
In the second study (Tang et al, 2003), 10 men and 12 women ingested 6 mg P-
carotene-dg, and three days later, 3 mg of retinol-dg as reference dose. Multiple blood 
samples were collected over 56 d. The average conversion factor was 9.1 to 1 by wt or 4.8 to 
1 by mol. The conversion efficiency was positively correlated with body mass index. The 
postabsorptive conversion of P-carotene was estimated as 7.8%, 13.6%, 16.4%, and 19% of 
the total converted retinol at 6, 14,21, or 53 d aAer the P-carotene-dg dose, respectively. 
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Since at 53 d after dosing the conversion of p-carotene was 19% of the total converted 
retinol, therefore of the total retinol converted from a p-carotene dose, 81% was from 
intestinal cleavage, and 19% was from extraintestinal cleavage. 
Postprandial TRL approach and extrinsic stable isotope reference method 
van Vliet et al (1995b) showed that the plasma triacylglycerol-rich lipoprotein 
fraction (TRL, d < 1.006 kg/L) may be useful in the assessment of P-carotene uptake and 
intestinal metabolism to retinyl esters after an oral dose of P-carotene. The advantage of the 
TRL approach is the use of the chylomicron-rich fraction, which contains newly absorbed P-
carotene. However, interpretation of TRL data is limited by the lack of means to control for 
inter-individual variation in clearance kinetics or variation in chylomicron recovery during 
TRL preparation and analysis (Parker 2000). Edwards et al (2001, 2002) adapted the TRL-
model by co-administering a small quantity of 10,19,19,19-^H4-retinyl acetate (d*-RA) in a 
maximally bioavailable form (oil solution) together with carotenoids from food sources. The 
authors argued that this extrinsic reference dose controlled for variation in chylomicron 
kinetics m vivo, and for retinyl ester recovery during TRL preparation and analysis. The 
extrinsic dose was also a reference. The mass of unlabeled vitamin A derived Aom intestinal 
cleavage of provitamin A carotene from a test meal could be estimated by comparison with 
the mass of the extrinsic reference dose. 
The investigators applied the extrinsic stable isotope reference method to study the 
vitamin A potency of P-carotene from various food sources, including raw carrots, spinach, 
carrot puree (commercial baby food), and boiled-mashed carrots. In the first study (Edwards 
et al, 2001), three adults consumed a standardized test meal containing 6 mg P-carotene as 
either raw carrot or spinach, with either 1 g or 20 g added fat, and 6.0 pmol ck-retinyl acetate 
as the extrinsic reference. To calculate masses of absorbed do-retinol and carotene, the 
authors assumed a 80% absorption of the cU-RA reference dose, based on previous studies of 
retinol absorption in humans (Olson 1987, Sivakumar and Reddy 1972, Goodman et al 
1966). Plasma concentrations of cLrretinyl ester, do-retinyl ester, and P-carotene peaked 
between 4.5 and 5.5 h after all high-fat trials, regardless of the food sources of P-carotene, 
and returned to near baseline around 7 h. In contrast, after the low-fat test meals, the 
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absorption profile was attenuated and prolonged. The results showed that with 20 g fat and 
assuming central cleavage, 7 ± 5% (range: 3%-16%) of the 6 mg P-carotene ingested was 
taken up (total absorption) with 0.3 ±0.1 mg as retinol (conversion). If a stoichiometry of 
conversion of 1:1 was assumed, the calculated percentage of p-carotene taken up from the 
high At vegetable meals was 11 ± 7%. In the high-fat trials, the estimated mass of retinol 
derived from 6 mg of P-carotene in raw carrot or spinach ranged from 0.14 to 0.51 mg. The 
mean observed equivalency ratio for these raw vegetables under ample fat condition was 
27:1 or 23:1 respectively, if the potential contribution of a-carotene in the carrots was 
ignored. This study showed that the bioefBcancy of P-carotene from raw carrots and spinach 
was low, and the At content of a meal had impact on the uptake of P-carotene from the meal. 
In a second study (Edwards et al, 2002), 9 healthy adults consumed test meals of 
either carrot puree (commercial baby food) or boiled-mashed carrots on separate days. Of 
the 9 subjects, 6 also consumed a test meal of raw grated carrot. Test meals supplied 34.7 
jimol (18.6 mg) P-carotene and 6 pmol deuterium-labeled retinyl acetate (cL-RA) in oil 
solution. The results showed that absorption of P-carotene and a-carotene was 
approximately 2-fbld greater from carrot puree than from boiled-mashed carrots, whereas the 
retinol yield was only marginally influenced by treatment. Carotene and retinyl ester 
absorption Aom raw-grated carrot was intermediate to, and did not differ significantly from, 
cooked preparations. Assuming 80% absorption efficiency of the df-RA reference, 0.44 ± 
0.15 mg of P-carotene (2.4 ± 0.8%) was absorbed intact from carrot puree, which was 
significantly higher than the 0.16 ± 0.11 mg p-carotene (0.9 ± 0.6%) absorbed Aom boiled-
mashed carrot. An estimated 0.38 ± 0.28 mg P-carotene (1.7 ± 1.3%) was absorbed intact 
from raw carrots. The carrot puree yielded 0.53 ± 0.2 mg vitamin A, the boiled-mashed 
carrot yielded 0.44 ± 0.17 mg of vitamin A, and the raw carrot meal yielded 0.43 ± 0.27 mg 
vitamin A. The apparent P-carotene conversion efficiency, defined as the proportion of P-
carotene taken up by the intestine that was metabolized to retinol, was 44 ± 11% (range: 24-
58%) for carrot puree, significantly lower than 59 ± 12% (range: 36-72%) for boiled-mashed 
carrots. For raw-carrots, the apparent conversion efficiency was 63 ± 10% and was not 
different from either of the cooked carrot treatments. These results showed that food 
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processing and cooking methods had impact on the bioavailability and bioconversion of P-
carotene to vitamin A in carrots. 
Long-term kinetic study of p-carotene using accelerator mass spectrometry 
In general, the studies reviewed above used relatively large doses of P-carotene. 
Accelerator mass spectrometry (AMS) detection and mass balance were used to study the 
concentration-time course of a physiological (306 |ig, 200 nCi) oral dose of ^C P-carotene 
for 209 days in plasma in 1 subject. AMS is an isotope ratio instrument that measures 
^C/^C ratio to parts per quadrillion (10"^), quantifying labeled biochemicals to attomolar 
(10"^) levels in milligram-sized samples. At attomolar levels of sensitivity, the radiation 
exposure is decreased to negligible levels. 
In two studies (Dueker et al 2000, Hickenbottom et al 2002), ^C-P-carotene, ^C-
retinyl esters, '^C-retinol, and several other '^C-retinoic acids were analyzed. ^C analytes 
appeared 5.5 h aAer dosing. Labeled p-carotene and its cleavage product ^C retinyl esters 
showed nearly identical kinetic profiles over the first 24-h period. Cumulative urine and 
stool samples were collected for 17 and 10 days, respectively. In the stool 57.4% of the dose 
was recovered within 48 hours postdosing. The stool was the major excretion route for the 
absorbed dose. The turnover time for P-carotene and retinol were 58 and 302 days, 
respectively. Area under the curve (AUC) analysis of the plasma response curves suggested 
a molar vitamin A value of 0.53 for P-carotene, with a minimum of 62% of the absorbed p-
carotene cleaved to vitamin A. The data also suggested that retinyl esters derived Aom p-
carotene may undergo hepatic resecretion in VLDL in a process similar to that for P-
carotene, because retinyl ester and P-carotene concentration-time courses were parallel for 24 
h postdosing. 
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Study of p-carotene metabolism by using ^C-(3-carotene and high-precision isotope 
ratio mass spectrometry 
Isotope ratio mass spectrometers (IRMS) are highly specialized mass spectrometers 
designed for the high-precision determination of isotope ratios for C, H, N, O, or S (Brenna 
et al 1997). Unlike organic mass spectrometers, samples must be converted to one of several 
gases prior to introduction to the IRMS. For C, samples are usually combusted to yield CO2, 
with an isotope ratio representative of the material of interest. Carbon dioxide is admitted to 
a tight electron impact (EI) ion source and produces molecular ions at M/Z 44, 45, and 46, 
which are monitored continuously using three Faraday cup detectors. The beams are 
comprised primarily of^C'*Oz, ' VO% + ' W*0, and ' W*0. The M/Z 46 signal is 
used to adjust M/Z 45 for the contribution of'^O, yielding a ratio of ^C/^C. For tracer 
applications employing a baseline correction, the ^O correction is negligible and can be 
ignored (Brenna et al 1997). 
The distinguishing characteristic of IRMS is measurement at high precision, which is 
defined as a standard deviation in the range of 4-6 significant figures (Brenna 1994, Brenna 
et al 1997). High precision is accomplished at the expense of flexibility. The electron 
impact ion source is tight so as to maximize ionization probability, which sets a requirement 
for gases of high volatility and low reactivity. This limits IRMS to analysis of the pure gases 
of CO;, H2, Nz, NzO, NO, O2, CO, and SO2, or SPg. "C/^C, WH, 'W*N, ^O/^O, and 
^S/^S analyses are performed through analysis of these gases. For continuous flow 
applications, these gases will usually be analyzed in helium carrier gas (Brenna 1994, Brenna 
et al 1997). 
Since 1990, gas chromatography (GC) interfaced to IRMS by means of an inline 
microcombustion furnace (GC-C-IRMS) has been available commercially and has facilitated 
high-precision determination of'^C/^C and ^N/'*N from mixtures separated by GC. 
Components of commercial instruments include metal oxide combustion furnaces and either 
Nafion™ or cryogenic water traps. The GC is a standard capillary system with split/split less 
or on-column injectors. The GC effluent is directed to a combustion reactor, which is 
normally a ceramic or quartz tube with capillary connections at the entrance and exit. The 
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reactor is typically loaded with a metal oxide derived from oxidizing metal wire, such as Cu, 
sometimes along with Pt catalyst to promote completion of the oxidation reaction. CuO is a 
source of O2 under 850°C. The replenishing or recharging of Cu to CuO can be 
accomplished automatically by including a small amount of O2 in the stream of carrier gas 
flowing through the furnace between samples, or more often it can be completed by 
introducing a stream of O2 or air into the furnace for several hours or overnight at 500°C. 
Solvent peaks are diverted from the furnace by a backflush switching of flow pressure under 
computer control, or an automatic rotary valve, to avoid prematurely depleting this reagent. 
CO2 and H?0 are the products after organic analytes are combusted in the furnace. 
Water is removed prior to admission to the ion source by either a Nafion™ tube or a 
cryogenic trap, because water reacts with CO2 to produce HCO2 , which interferes with 
analysis at m/z 45. As analyte CO2 passes through the ion source, three traces, representing 
masses 44, 45, and 46, are recorded. For CO2, the relative gains in Finnigan MAT 252 are 3 
to 200 to 1000 for m/z 44, 45, and 46 channels. A commonly observed phenomenon is that 
that 45 peak elutes prior to 44 peak, causing a "positive-negative-going" ratio trace. This 
reversal is thought to be due to differences in intermolecular interactions between the 
isotopically substituted peaks and all ^C peaks. These traces are used to generate integrated 
areas by applying either the summation or curve-fitting algorithms. Isotopic calibration is 
accomplished if one of the peaks in the chromatograms is an internal standard, or more 
commonly and conveniently, a pulse of calibrated CO2 from a gas bottle is admitted to the 
ion source through a separate inlet during a period when no peaks elute from the GC. For 
carbon, the minimum sample size required to yield a precision of SD (8^C) less than 0.3%o is 
about one nmol carbon. 
The dynamic range over which enrichments can be accurately and precisely measured 
by GC-C-IRMS is limited. Brenna et al (1997) suggested that carbon isotope ratio much 
above 8^C = 1000%o will comprise precision and accuracy, partly due to the large difference 
in isotope ratio as compared with natural abundance standards. Since the amplification 
among the channels are set to produce natural abundance signals of equal magnitude and 
expected to measure simultaneously the ratio anticipated for the enriched samples and for the 
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baseline samples, this limitation problem cannot easily be solved even by using enriched 
standards. 
SYWy of /Z-carofene wsmg GC-C-ZRM9 
Parker et al (1993) first applied GC-C-IRMS to the study of p-carotene metabolism. 
In their preliminary study, they successfully administered an oral dose as low as 0.5 mg to a 
subject and measured the metabolism and plasma biokinetics of ^C-P-carotene from algae 
using GC-C-IRMS. Later in a study (Parker et al 1997), they extracted and purified 
perlabeled ^C-p-carotene (> 95% ^C) from a crude hexane extract of unicellular green algae 
that were grown with ^C-labeled CO2 as the sole carbon source. The results showed that at 
the times corresponding to the maximum concentration of each ^C-labeled analyte during 
the 22-h period, the proportion of total analyte existing in the plasma as the labeled species 
was approximately 1.2% for p-carotene, 0.8% for retinol, and 9.2% for retinyl ester. Most of 
the absorbed dose was converted to vitamin A, with retinyl esters predominating. Assuming 
that all three analytes were removed from the plasma at the same rate, about 64% (a molar 
basis) of absorbed ^C from ^C-P-carotene entered the plasma as retinyl esters, 21% as 
retinol, and 14% as intact P-carotene. 
They applied the same method to study ^C-p-carotene metabolism in a group of male 
subjects ranging in age from 27 to 41 years (Swanson et al 1996). The subjects were given 1 
mg ^C-P-carotene. Short-term (0 - 50 h) and long-term (0 - 600 h) kinetics of plasma Re­
labeled p-carotene, retinyl ester, and retinol were studied. The labeled P-carotene and retinyl 
ester peaked 5h after dosing, corresponding to the known kinetics of chylomicrons, and 
represented absorption of unmetabolized ^C-labeled p-carotene and its major intestinal 
metabolite, ^C-retinyl esters. The second broad peak of labeled P-carotene between 24 and 
48h reflected hepatic secretion of P-carotene in very low density lipoproteins (VLDLs) and 
subsequent lipolysis of VLDL to lower density lipoproteins. ^C-retinol, a minor intestinal 
metabolite of ^C-p-carotene, exhibited a single peak at about 12 h, reflecting hepatic 
secretion of the retinol-binding protein-transthyretin complex. 
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You et al (1996) applied this method to study the isomerization of 9-cw-(3-carotene 
during absorption in humans. Three subjects were given 1.0 mg ^C-(3-carotene of which 
99.4% as in the 9-cts form. The results showed a significant proportion of the ^C-9-CL?-(3-
carotene dose was isomerized to the all-fram? form before entering the blood stream. 
Vitamin A status assessment is not as simple as determining plasma or serum 
concentrations of retinol, because serum concentrations of retinol are homeostatically 
controlled and do not begin to decline until liver reserves are dangerously low (Underwood 
1984). Direct assessment of liver storage of vitamin A can be achieved by liver biopsies but 
this method is only justified under unusual circumstances. Indirect measurements of liver 
reserves are more practical and useful. Vitamin A assessment methods that will accurately 
determine the liver reserve of populations using a minimum number of blood samples are 
still in development (Tanumihardjo 2000). The deuterated vitamin A assay has been 
successfully applied in several population groups, but a large dose of vitamin A (35-140 
|imol for adults) must be used due to the low sensitivity of GC-MS analysis (Furr et al 1989, 
Haskel et al 1998, Ribaya-Mercado et al 1999). Tanumihardjo (2000) developed an isotope 
dilution method in a rat model by using '"C-labeled retinol and GC-C-IRMS. This method 
requires only physiological doses of retinol and routine venipuncture techniques. The 
calculated and measured values of total body reserves of vitamin A were 7% of each other 
overall, and the relationship was linear. The serum retinol concentrations did not show 
differences among different groups. The author concluded that this method offers more 
sensitivity than traditional methods and may be applicable to human vitamin A status 
assessment when total body reserve estimations are desired. 
OfAer app/icafzofis of GC-C-TRMS" m carofeMo;W 
Liang et al (1998) used GC-C-IRMS to determine the natural abundance ^C in lutein 
isolated from C3 and C4 plant sources. The C3 and C4 photosynthetic pathways differ in the 
isotopic discrimination of the initial carboxylating enzyme that incorporates CO2 from the 
atmosphere. As a result the ^C content of C* plants is higher than that of C3 plants. Carbon 
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isotope fractionation in plants is potentially useful for studies of the bioavailability and 
metabolism of ^C-enriched lutein derived from C# plant foods in animal models or humans. 
In their study, they used GC-C-IRMS to determine the stable carbon isotope ratios of lutein 
isolated from a C3 (marigold flower) and a C4 (com gluten meal) plant source. The ô'^C 
value was -19.77 ± 0.27%o for lutein isolated from com gluten meal, which was significantly 
different from the ô'^C value of -29.90 ± 0.20%o for lutein isolated from marigold flower. 
This is the first study that developed a method to analyze a carotenoid other than P-carotene 
by using GC-C-IRMS. 
Yao et al (2000) used a ^C tracer and GC-C-IRMS to quantify the plasma appearance 
of a physiological dose of lutein in humans. Biosynthetic per labeled (>99% ^C) lutein was 
purified from a commercially-available extract of algal biomass. Subjects (n = 4) ingested 3 
mg of ^C lutein with a standardized low-carotenoid breakfast. Blood samples were collected 
at baseline and then hourly for 12h; additional blood samples were drawn at 16,24,48, 72, 
96, 192, 360, and 528 h. Plasma lutein was purified by using HPLC and hydrogenated on 
palladium-on-carbon catalyst with acid-catalyzed hydrogenolysis. The hydrogénation 
product ,perhydro-(3-carotene, was injected into the GC-C-IRMS and the stable isotope 
(^C/^C) ratio was measured. Plasma concentrations of ^C-lutein were calculated based on 
the ^C/^C ratio and the total plasma lutein concentration. The results showed a rapid 
increase in '^C lutein in plasma until 16 h after dosing, followed by a decline until 24 h. A 
small increase in ^C-enrichment from baseline could still be measured in plasma lutein at 
528 h. This study is a successful adaptation of the ^C-tracer approach developed by Parker 
et al (1993, 1997). In this study, a tracer approach and GC-C-IRMS were used to study the 
metabolism of another predominant dietary carotenoid, lutein. The tracer method and use of 
GC-C-IRMS offers a sensitive and selective experimental approach to study the absorption 
and metabolism of lutein when ingested in physiologically relevant amounts by humans. 
Study of P-carotene metabolism by using LC-MS 
Liquid chromatography-mass spectrometry (LC-MS) has been used to study the 
metabolism of P-carotene. LC-MS methods are sensitive and do not involve extensive 
sample preparation. Therefore they could potentially be useful for large-scale comprehensive 
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studies. Pawlosky et al (2000) used a combination of liquid chromatography/particle beam-
mass spectrometry (LC/PB-MS) to study the metabolism of P-carotene-dg in humans. In this 
study, one subject ingested a 5 mg dose of p-carotene-dg, and blood samples were collected at 
0 h, 8 h, 8 d, 15 d, and 29 d. The results showed a detection limit of about 0.6 pmol for p-
carotene. Using P-carotene-^C^ as an internal standard P-carotene-dg could be quantified 
over a concentration range of two orders of magnitude. The concentration of P-carotene-dg 
appeared to reach the maximum at 8 h. Using the same approach this group determined Re­
labeled and endogenous P-carotene, lutein, and vitamin A in the plasma of a subject who 
consumed kale that has been grown in a ^COi-enriched atmosphere (Kelm et al 2001). 
Internal standards including ^Hg-P-carotene, P-apo-8'-carotenal and ^-retinol were used to 
quantify the ^C/^C isotopomers of P-carotene, lutein, and retinol, respectively. 
High-performance liquid chromatography-atmospheric pressure chemical ionization 
mass spectrometry (APCI LC-MS) was developed to quantify the bioavailability of retinyl 
palmitate and p-carotene and the bioconversion of P-carotene to retinol in humans(Wang et 
al 2000, van Lieshout et al, 2001). In their study, subjects were given physiological doses of 
[8,9,10,11,12,13,14,15,19,20-RCio]-retinyl palmitate and [12,13,14,15,20,12',13',14',15',20'-
^Cioj-P-carotene. Plasma retinol and P-carotene were extracted analyzed with reverse-phase 
HPLC interfaced to an APCI mass spectrometer. No further purification or derealization of 
retinol or p-carotene was necessary. APCI LC-MS showed a linear detector response for p-
carotene over 4 orders of magnitude. APCI LC-MS is a simple, straightforward analytical 
approach that is sensitive and specific. It does not require the high resolution of tandem mass 
spectrometry. The detection limit for P-carotene was determined to be 0.5 pmol injected on-
column, which makes it suitable for studies using small doses of labeled P-carotene doses. 
APCI LC-MS was applied to study the bioefficacy of P-carotene dissolved in oil 
when ingested by Indonesian children (van Lieshout et al, 2001). Children aged 8-1 ly (n = 
35) consumed 160 pg of [12,13,14,15,2,12',13',14',15',20'-RCto]-P-carotene (with a franc to 
cÂs ratio of 3:1) and 160 |ig of [8,9,10,11,12,13,14,15,19,20-^Cio]-retinyl palmitate, in the 
form of capsules, seven days a week for ten weeks or less. Different study durations were 
chosen to assess the time required for the isotopic enrichment of retinol and P-carotene in 
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serum to reach a plateau. A total of three blood samples were drawn over this period. 
Isotopic enrichment in serum retinol with and ^Cio and in p-carotene with ^Cm were 
measured using APCI LC-MS. The results showed that isotopic enrichment in both plasma 
retinol and P-carotene reached plateau by day 21. The amount of p-carotene in oil required 
to form 1 jiig retinol was 2.4 p.g with the trans:cis ratio of 3:1 in the dose. This number is 
superior to the 1 pg retinol from 3.3 p,g P-carotene previously estimated. Bioefficacy is a 
new term introduced in this paper. It is defined as the amount of ingested provitamin A 
required to yield 1 pg retinol in the body. 
Besides having the advantages shared by all stable isotope tracer approaches, this 
method offers several special advantages. The use of multiple doses enables the isotopic 
enrichment to reach a plateau, which makes analysis of data and subsequent calculation and 
interpretation of results easier than in single-dose studies. This method does not require 
extensive purification and derivatization of P-carotene and retinol. In their editorial, 
Solomons and Russell (2001) regard this stable-isotope approach as "appropriate technology" 
for vitamin A field research. This approach might be extended to address the question of 
vitamin A potency of P-carotene in fruits and vegetables. 
Summary 
Stable isotope tracer techniques are relatively new tools for studying in humans the 
bioavailability and bioconversion of dietary carotenoids, particularly P-carotene. Use of such 
techniques have several advantages, including the possibility of administering P-carotene 
doses that are similar to dietary intake, therefore providing more reliable and representative 
data about the bioavailability and bioconversion of P-carotene from food source. This 
information can help the scientific community to better understand food-based approaches to 
eliminating vitamin A deficiency worldwide. A recent review (Lieshout et al 2003) provides 
a step-by-step discussion of aspects related to the isotopic techniques fbr studying of 
bioavailability and bioefRcacy of dietary carotenoids, including study design, choice of 
isotopic tracers, dosing regimen, collection of samples, chemical analysis of samples, and 
data analysis. 
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Part HI. Molecular characterization of p-carotene cleavage enzymes 
Introduction 
When doses are low, the majority of the ingested P-carotene is cleaved at the central 
carbon 15,15'-double bond to form two molecules of retinal (Olson and Hayaishi 1965, 
Bloomstrand and Werner 1967; Goodman et al 1965). The enzyme that catalyzes this 
reaction was named P-carotene 15,15'-dioxygenase (Goodman et al 1965, Olson and 
Hayaishi 1965). The enzyme was first described about 50 years ago (Moore 1957). 
Subsequent biochemical characterization suggested the enzyme is a soluble, cytosolic 
enzyme (Goodman et al 1966a, 1966b, Fidge et al 1969) and its enzymatic activity depends 
on an iron-containing cofactor (Fidge et al 1969, Lakshmanan et al 1972). The enzyme is 
associated with a high-molecular-mass lipid protein aggregate fraction (Sklan 1983). In 
mammals, the highest carotene oxygenase activity is found in intestinal mucosa, and more 
specifically, jejunum enterocytes, with a gradient of decreasing activity from 
duodenum/jejunum to colon (Duszka et al 1996, van Vliet et al 1996). The enzymatic 
activity has also been found in liver, lung, kidney, and brain (During et al 1996). Assuming 
an optimal p-carotene/retinal cleavage ratio of 1:2, the maximum capacity of P-carotene 
cleavage in an adult was estimated to be 12 mg/day, one 6Ah by small intestine and four 
fiAhs by liver (During et al 2001). 
This enzyme was regarded as a dioxygenase until recently, when Leuenberger et al 
(2001) showed that the reaction mechanism of the cleavage of the central carbon 15,15'-
double bond in P-carotene involves a monooxygenase-type mechanism. In their experiments 
using labeled oxygen molecules, only one '^O atom of molecular oxygen was incorporated in 
the reaction and the other O atom was ^O from labeled water. Thus, the enzyme was 
renamed p-carotene 15,15'-monooxygenase. This monooxygenase mechanism resembled the 
mechanism proposed by the same research group for a supramolecular enzyme model 
catalyzing the regioselective cleavage of P-carotene (French et al 2000). 
The reaction mechanism of P-carotene monooxygenase had been controversial (Wolf 
1995). Central cleavage leading to the formation of two retinal molecules was accepted as 
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the major metabolic pathway for retinoid formation from P-carotene. Eccentric cleavage of 
P-carotene leading to the formation of apocarotenals was first proposed by Glover et al in 
1960, and is supported by some recent Wvo and m W/ro studies. Wang et al (1991) found 
retinoic acid as the only metabolite after incubation of p-carotene with intestinal 
homogenates of humans, monkeys, ferrets, and rats. Yeum et al (2000) suggested that P-
carotene was converted exclusively to retinal by central cleavage in the presence of an 
antioxidant such as a-tocopherol, but cleaved randomly by enzyme-related radicals to 
produce P-apo-carotenoids in the absence of an antioxidant. Recently, Wirtz et al (2001) 
used a partially-purified chicken intestine enzyme preparation and isomerically pure a-
carotene as substrate to investigate the substrate specificity of p,p-carotene 15,15'-
monooxygenase. The results suggest that this enzyme has a rather rigid binding site in which 
the substrate-protein interaction determines the absolute preference to cleave the central 
carbon 15,15'-double bond of the carotenoids that are at least "half-identical" to p,p-
carotene, with one "natural", unsubstituted P-ionone ring (Wirtz et al 2001). Kiefer et al 
(2001) identified and characterized a second type of carotene monooxygenase that catalyze 
exclusively the asymmetric oxidative cleavage of P-carotene at the 9', 10' double bond, 
resulting in formation of P-apo-10'-carotenal (Cz?) and p-ionone (Cu). Therefore new studies 
seem to provide evidence to bring an end to the controversy (Wolf 2001). The central and 
eccentric cleavage of p-carotene both exist but are controlled by different enzymes. 
The enzymatic activity of the p-carotene cleavage enzyme is regulated by nutritional 
status and dietary factors. The activity of P-carotene 15,15'-monooxygenase is positively 
correlated with iron concentration and negatively correlated with copper concentration in the 
small intestine in rats (During et al 1999). Its activity is iron-dependent (During e al 2001). 
Protein deficiency lowers the level of enzymatic activity in rats (Parvin and Sivakumar 
2000). Vitamin A intake affects the enzymatic activity of P-carotene 15,15'-monooxygenase. 
Without P-carotene supplementation, the intestinal monooxygenase activity was 90% higher 
in rats fed with a low vitamin A diet than in rats fed with a high vitamin A diet (van Vliet et 
al 1996). Supplementation of P-carotene significantly lowered the enzymatic activity of p-
carotene monooxygenase. A diet rich in polyunsaturated triacylglycerols enhanced the p-
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carotene monooxygenase activity in rat intestine (During et al 1998). Dietary ûavonoids 
inhibited P-carotene 15,15'-monooxygenase activity m vzfro using a pig intestinal 
homogenate as the enzyme source. The inhibitory effect of flavonoids was also confirmed in 
cultured Caco-2 cells (Nagao et al 2000). 
Lutein and other carotenoids affect the enzymatic activity of p-carotene 15,15'-
monooxygenase in in vitro studies. Canthaxanthin inhibited P-carotene monooxygenase in 
rat intestine both m and m Wfro (Groher et al 1997). An m vzfro study measured P-
carotene cleavage activity with the 9,000 x g-supematant from rat and hamster intestinal 
homogenates. Addition of 9 pg lutein to the incubation with 3 |ig of p-carotene reduced 
retinal formation, whereas lycopene had no effect (van Vliet et al 1995). Lycopene, lutein, 
and astaxanthin competitively inhibit the enzymatic activity of P-carotene 15,15'-
monooxygenase isolated from rabbit small intestinal mucosa (Ershov et al 1993). 
The activity of p,p-carotene 15,15'-monooxygenase is regulated by its direct 
metabolites in rats and chickens (Bachmann et al 2002). There were dose-dependent 
decreases in intestinal P,p-carotene 15,15 '-monooxygenase activity after oral administration 
of retinyl acetate, P-carotene, apo-8'-carotene, all-fm?zs retinoic acid, and 9-czs retinoic acid. 
The activity of this enzyme in the liver was not affected. Apo-12'-carotenal and a retinoic 
acid receptor (RAR) a-antagonist significantly increased the intestinal enzymatic activity by 
55% and 94% respectively. Two cytochrome P450 (CYP) inducers increased the enzymatic 
activity in rat intestine. In chickens, a transcriptional study showed that treatment with 
retinoic acid resulted in low expression of the intestinal enzyme. 
The studies reviewed above have provided accumulated knowledge about the nature 
and characteristics of p-carotene 15,15'-monooxygenase. However the enzyme had not been 
purified and molecular data on this key step in vitamin A formation had been missing until 
the recent molecular identification and cDNA cloning of p-carotene 15,15'-monooxygenase 
from fruit fly (von Lintig and Vogt 2000) and chicken (Wyss et al 2000). Since then, P-
carotene 15,15'-monooxygenase has also been cloned in mouse and humans (Table 2). A 
mammalian enzyme that catalyzes the asymmetric oxidative cleavage of provitamin A 
carotenoids was also identified and characterized (Kiefer et al 2001). These findings opened 
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new perspectives to further study of the metabolism of p-carotene. Two different 
approaches, m vzvo studies such as stable isotope tracer approaches, and m vzfro incubation 
studies which characterize cloned and purified P-carotene 15,15'-monooxygenase, will 
complement each other and provide new information about absorption and bioconversion of 
P-carotene. 
Molecular identification of a P-carotene monooxygenase from Drosop/w/o me&mogosfer 
von Lintig and Vogt (2000) cloned and identified, for the first time, a P-carotene-
cleaving enzyme in fruit flies. They used a novel test system consisting of a p-carotene 
synthesizing and accumulating Esc/zerzc&za co/z strain. The expression of a p-carotene 
15,15'-monooxygenase in the genetic background of this & co/z strain results in the 
formation of retinoids and can be monitored by a color shift of the & co/z from orange (P-
carotene) to almost colorless due to the cleavage of P-carotene to retinoids. In plants, vpl4 
has been cloned and identified as the gene that encodes a protein that catalyzes the oxidative 
cleavage of 9-cza epoxy carotenoids at the 11-12 carbon double bond, to form xanthoxin, the 
direct precursor of abcisic acid (Schwartz et al 1997). A homologues of this plant 
carotenoid-cleaving enzyme was found in DrosqpAz/a meAzMogasfer. A full-length cDNA 
was cloned and used to directly test P-carotene monooxygenase activity. The results 
demonstrated that the cloned cDNA encodes a p-carotene monooxygenase (named P-diox), 
and the cleavage products of P-carotene were exclusively retinoids, showing a central 
cleavage pattern. The sequence analyses revealed that the cDNA encoded a protein of 620 
amino acids, with a calculated molecular mass of 69.9 kDa. The deduced amino acid 
sequence shares sequence homology to the plant carotenoid monooxygenase i%)14, to 
lignostilbene synthase from Aewdbmorza? powczmoMzas, and to several proteins of unknown 
function in the CyaMoWcferzwrn .Sfyrzec&ocy.s'fis. However, the highest sequence homology 
was to RPE65, a protein from the retinal pigment epithelium (RPE) in vertebrates. RPE 65 
and p-carotene 15,15'-monooxygenase share 36.7% overall sequence identity. The sequence 
comparison revealed that P-carotene 15,15'-monooxygenase belongs to a new class of 
monooxygenases described only in bacteria and plants, and RPE65 could be the vertebrate 
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equivalent to p-carotene 15,15'-monooxygenase. The 15,1 S'-monooxygenase mRNA was 
restricted exclusively to the head, whereas in the thorax and abdomen, no mRNA was 
detected. This protein is soluble and is not tightly associated with membranes. Its activity 
depends on iron, as previously reported. The apparent Km value for P-carotene was 
estimated to be 5 |iM. This enzyme was not able to use zeaxanthin as a substrate to directly 
form hydroxylated retinoids under the experimental conditions. 
The 15,15'-monooxygenase gene is located at position 87F on chromosome 3 in the 
Drosophila genome. A Drosophila mutant, ninaB, has been mapped in this region. The 
mutant phenotype has a reduced rhodopsin content in all photoreceptor classes. The mutant 
phenotype can be rescued by the dietary supplementation of retinol but not by P-carotene 
(von Lintig et al 2000). In two independent ninaB allés, mutations in the gene encoding 
15,15 '-monooxygenase were indeed found (von Lintig et al 2000). These mutations lead to a 
defect in vitamin A formation and are responsible for the blindness of these flies. 
Cloning and expression of p, p-carotene 15,15-monooxygenase in chicken 
Wyss et al (2000) cloned the first vertebrate p,P-carotene 15,15'-monooxygenase that 
symmetrically cleaves P-carotene at the 15,15-double bond. The isolated full-length cDNA 
for p,P-carotene 15,15-monooxygenase has a length of 3.1 kb. The coding sequence spans 
1578 bp and leads to a protein of 526 amino acids. The cDNA shows high homology to 
RPE65. When the enzyme was expressed in & co/z, retinal was the sole reaction product. 
No apocarotenals were detected, indicating that the enzyme specifically cleaves p-carotene at 
the 15,15'-double bond. When the enzyme was expressed in baby hamster kidney cells, 
enzymatic activity was found in the whole-cell and in the cytosolic extract, but not in the 
membrane fraction. The authors concluded that the chicken p,p-carotene 15,15'-
monooxygenase is a cytoplasmic enzyme of 60.3 kDa and is expressed primarily in 
duodenum. 
The expression pattern and localization of P,P-carotene 15,15-monooxygenase in 
different tissues in chicken and the homology between chicken, mouse and drosophila 
enzymes were studied (Wyss et al 2001). The regions of amino acids 97-108 and 132-155 of 
the enzyme were fbund almost identical between mouse and chicken, showing high 
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conservation during evolution. Overall, the chicken and mouse P, P-carotene 15,15'-
monooxygenases show 81% homology at the amino acid level, whereas the drosophila p-­
carotene 15,15'-monooxygenase show 50% homology with the chicken and 48% with the 
mouse. 
Northern blotting showed that p,P-carotene 15,15'-monooxygenase was expressed 
primarily in the digestive tract of chicken, with the highest expression being in the duodenum 
but remarkably lower expression in the ileum. In mouse, there was a strong expression of 
mRNA in liver, marginal expression in kidney, and no expression in lung. In mouse testis, 
there were three distinct bands, which may represent alternative splicing products of a single 
gene or three distinct p,p-carotene 15,15'-monooxygenase genes. 
azfw hybridization was used to analyze the expression pattern of p,p-carotene 
15,15-monooxygenase in duodenum, liver, lung, ileum, and skin in chicken. In duodenum, 
the epithelial cells of crypts and villi were positively stained. Some stromal cells were also 
stained, hypothetically representing T- or B-cells, which suggests P-carotene may be 
converted to vitamin A in immune cells. 
Identification and expression of mouse enzymes that catalyze the symmetric and 
asymmetric cleavage of p-carotene 
Redmond et al identified the first mammalian P,P-carotene 15,15-monooxygenase in 
mouse (2001). The mouse cDNA has 2120 bp and contains an open reading frame that is 
1698 bp in length. The cDNA encodes a protein of 566 amino acids, with a calculated 
molecular mass of 63.859 kDa. The deduced polypeptide does not have an obvious signal 
peptide, predicted transmembrane domains, or potential sites for N-linked glycosylation. 
The deduced mouse polypeptide showed 70%, 30% and 85% identities respectively 
with chicken, drosophila p,p-carotene 15,15-monooxygenase and a predicted product of a 
human cDNA without known function. The mouse p,P-carotene 15,15-monooxygenase has 
only 37% amino acid identity to mouse RPE65. There are 10 residues, including 4 histidine 
residues and 6 acidic residues, that are absolutely conserved in these sequences. There is 
also a well conserved region at residues 469-480 of mouse sequence. 
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Expression of mouse p, P-carotene 15,15-monooxygenase in P-carotene, e-carotene, 
and lycopene-accumulating E. co/z resulted in bleaching as a consequence of cleavage of the 
endogenous carotenoids. Purified recombinant P,P-carotene 15,15-monooxygenase cleaves 
P-carotene m Wfro with a Cmax of 36 pmol of retinal/mg of protein and a Km of 6pM. At 
levels of lycopene concentrations conçarable to the Km for P-carotene, no acyclic retinal 
was detected. However, trace amounts were seen at 2.5-times the P-carotene Km. 
In several tissues that are active sites of vitamin A metabolism, there was p,p-
carotene 15,15 '-monooxygenase mRNA accumulation. The major mRNA, seen in liver, 
kidney, testis, and small intestine, was 2.4 kb. The 2.4 kb message had low abundance in 
small intestine, which was explained by the authors as the results of dilution of mRNA 
caused by the outer muscular layers of the gut. Smaller messages were seen in testis and 
skin, particularly a 1.8 kb message is abundant in testis. Analysis of a mouse development 
blot showed a strong signal for the 2.4 kb message at 7 days post-conception, which declined 
as the development age increased. 
Paik et al (2001) also identified a cDNA encoding a mouse homolog of a carotene 
cleavage enzyme. The cDNA generated from a mouse kidney library showed 48% amino 
acid sequence identity to the Drosophila sequence. The full length cDNA includes 
polyadenylation sites and an open reading frame consisting of 566 amino acids. The protein 
deduced from this sequence has a molecular mass of 64,000. The sequences of chicken, 
mouse, and human have an identity of 65%. The sequences of mouse and human have 85% 
identity. 
When the cDNA was expressed in either E. co/z or Chinese hamster ovary cells, 
expression conferred upon bacterial and Chinese hamster ovary cell homogenates the ability 
to cleave P-carotene to retinal. All fraw-retinal and some 13-cw-retinal (<10% of all fraw-
retinal) were sole products that could be detected upon incubation of all-frans-p-carotene 
with the recombinant protein, and no apocarotenals were observed. The dependence of 
reaction velocity showed a sigmoidal relationship with p-carotene concentration. Analysis of 
the kinetic data gave rise to a Ko.; for P-carotene of 0.95 pM, a V^ax of 368 pmol/mg/h, and a 
hill coefficient of 0.659. Addition of iron chelating agents decreased the activity of this 
enzyme. 
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Kinetic analyses of the recombinant enzyme suggested that this enzyme interacts with 
other proteins present within cell or tissue homogenates. An atypical testis-specific isofbrm 
of lactate dehydrogenase (LDH-C) is associated with recombinant carotene cleavage enzyme. 
The authors suggested that if LDH-C could catalyze either retinal reduction to retinol or 
retinal oxidation to retinoic acid, the association between the recombinant enzyme and LDH-
C could mean that p,p-carotene 15,15-monooxygenase acts physiologically in concert with 
other proteins involved in retinoid metabolism. 
The mRNA of 15,15'-monooxygenase is expressed most highly in the testis followed 
by the liver and kidney. Surprisingly, no expression was detected in the small intestine using 
Northern blot analysis. However, RT-PCR analysis using total RNA could detect the express 
in small intestine. The authors contributed this observation to species differences, or the use 
of the entire small intestine instead of only the proximal portion of the small intestine. The 
testis expressed two transcripts, 2.6 kb and 1.7 kb. The smaller sized transcript is missing a 
portion of 5'-region of the cDNA. 
The expression pattern of carotene 15,15'-monooxygenase during early stages of 
mouse embryogenesis was also investigated. j/fw hybridization showed that at embryonic 
days 7.5 and 8.5, mRNA for this enzyme is highly expressed in maternal tissue surrounding 
the embryo but is not present at detectable levels in embryonic tissues. 
In all the studies mentioned above, the sole cleavage product of the carotene 15,15'-
monooxygenases identified is all-frams-retinal, with small amount of 13-ci?-retinal as 
addition. Asymmetric cleavage product has not been observed in any of these studies, which 
showed that carotene 15,15'-monooxygenase only cleaves the double bond at the 15,15' 
position. If asymmetric oxidative cleavage of carotene does exist, this reaction must be 
catalyzed by an enzyme or enzymes other than carotene 15,15'-monooxygenase. Kiefer et al 
(2001) identified and characterized in mouse, human, and zebrafish cDNAs that encode a 
second type of carotene monooxygenase that catalyze exclusively the asymmetric oxidative 
cleavage of p-carotene at the 9', 10' double bond, resulting in formation of P-apo-10'-carotenal 
(C27) and p-ionone (C13). Besides P-carotene, lycopene is also oxidatively cleaved by this 
enzyme. 
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The cDNA encoding the new type of carotene monooxygenase encoded a protein 
(named p-diox-II by the authors) of 532 amino acids. The amino acid sequence shared 39% 
identity with the mouse p,p-carotene 15,15'-monooxygenase. Several highly conserved 
stretches of amino acids and six conserved histidines probably involved in binding of the 
cofactor Fe^ were found, indicating that the encoded proteins belong to the same class of 
enzymes as p,P'-carotene 15,15'-monooxygenase. 
To test its functional characterization, the authors expressed P-diox-II as a 
recombinant protein in & Co// and performed both z/z Wfro and z« vzvo analyses. The 
cleavage product was identified to be P-apo-10'-carotenal by using HPLC and LC-MS. The 
HPLC method did not detect P-ionone, which the authors explained was due to its volatility 
and/or its partitioning to the medium. The bacterial growth medium was analyzed after solid 
phase extraction of lipophilic compounds by GC-MS and significant amount of P-ionone was 
detected in the medium. Based on these findings the authors named the enzyme p, p-carotene 
9', 10'-dioxygenase. This enzyme also catalyzes the oxidative cleavage of lycopene in the E. 
co/z test system. 
To verify the existence of this second type of enzyme in other metazoan organisms, 
the authors searched for expressed sequence tags (EST) with sequence identity in the data 
base, and found EST fragments from human and the zebrafish, and cloned the corresponding 
full-length cDNA. The cDNA cloned from the total RNA derived from human liver encoded 
a protein of 556 amino acids, whereas the cDNA isolated from the zebrafish encoded a 
protein of 549 amino acids. The deduced amino acid sequences shared 72% and 49% 
sequence identity respectively to the mouse P,P-carotene-9', 10'-dioxygenase. By performing 
a phylogenetic tree calculation, the authors concluded that the three groups of polyene chain 
monooxygenase, the two different P-carotene monooxygenases and REP65, mostly likely 
emerged from a common ancestor. In contrast, in Drmqp/zz/a and Caefzor/zaWfw e/egarzs, 
only one type of monooxygenase was found in the entire genome. 
Total RNA from several mouse tissues were analyzed by RT-PCR to estimate the 
steady-state mRNA levels of the two carotene cleavage enzymes. Both types of mRNAs are 
detected in the small intestine, liver, kidney, and testis, whereas low abundance steady-state 
mRNA of p,P-carotene 9', 10'-dioxygenase was additionally present in spleen, brain, and 
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heart. A 2.2 kb message was found in heart and liver for p, p-carotene 9', 10'-dioxygenase, 
whereas a transcript of 2.4 kb was found mainly in kidney. 
Cloning and characterization of human p,p-carotene 15,15 -monooxygenase 
Yan et al cloned the first human p,p-carotene 15,15'-monooxygenase in 2001. The 
open reading frame of the cloned human cDNA encodes a protein of 547 amino acids with a 
calculated molecular mass of 62 kDa. The predicted amino acid sequence shows 67% 
identity and 80% similarity to a chicken sequence (Wyss et al 2000). Homology between 
human and chicken sequences is distributed Airly equally throughout the entire protein, but 
the human enzyme has an extra 20 amino acid residues at its carboxyl terminus. For 
comparison, the authors also obtained and sequenced from the GenBank, a murine protein of 
566 amino acids that has 83% identity with the human clone. Most of the variations between 
the human and the murine clones are located at the carboxyl terminus. The human clone has 
a 24% homology to the Drosophila clone. The alignment of the human p,p-carotene 15,15'-
monooxygenase and the human RPE65 reveals four areas of increased sequence 
conservation, two of which have particularly high and specific homology. 
The gene structure and chromosomal localization of human p,P-carotene 15,15'-
monooxygenase were determined. The gene spans approximately 20 kb and consists of 11 
exons and 10 introns. Exons range in size from 95 to 795 bp. Intron sizes range from 660 bp 
to 3 kb. All the 5'-donor and 3'-acceptor sites are consistent with the GT-AG consensus for 
premRNA splicing recognition sequences. Several potential initiation sits were identified, 
with the major site at 216 bp upstream of the initiation methionine, consistent with the 
existence of a typical TATA box 30 bp upstream of the transcription site. 
The chromosomal localization of human P,P-carotene 15,15'-monooxygenase was mapped to 
chromosome 16q21-q23, close to the BBS2 locus for Bardet-Biedl syndrome, an autosomal 
recessive disease associated with abnormalities of retinoid metabolism. 
Northern analysis indicates that p,P-carotene 15,15'-monooxygenase gene is highly 
expressed in human RPE as a 2.4 kb transcript, 0.7 kb shorter than the chicken gene 
transcript. Human p, P-carotene 15,15 '-monooxygenase preferentially expressed in the RPE, 
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but also expressed at lower levels in kidney, testis, liver, and brain, and the level of 
expression in intestine seems similar to that in kidney but lower than that in RPE. 
To study the biochemical characteristics of human p-carotene 15,15'-
monooxygenase, these researchers expressed the enzyme using a baculovirus system. All-
frafM-retinal and small amount of 13-cw-retinal were identified as products of P,p'-carotene 
cleavage. The enzymatic activity was significantly reduced by addition of EDTA, an iron 
chelating agent. The enzyme showed substrate specificity. Lutein and lycopene were not 
cleaved by this enzyme under the similar conditions used for P,P'-carotene assay. 
Recently, Lindqvist and Andersson (2002) also characterized a purified recombinant 
human p-carotene 15,15'-monooxygenase. A highly active enzyme was expressed and 
purified to homogeneity from baculovirus-infected /rwgzpendo 9 insect cells. The 
Km and Vmax of the enzyme for p-carotene were 7 pM and 10 nmol retinal/mg x min, 
respectively. These values corresponded to a turnover number (Kcat) of 0.66 min"' and a 
catalytic efficiency (Kcat/Km) of-10^M"'min"'. The specific enzymatic activity is 300-fbld 
higher than that of the partially purified enzyme from chicken intestinal mucosa (Wyss et al 
2000), and 300-1600-fbld higher than that of the partially expressed and purified mouse 
enzymes (Redmond et al 2001, Paik et al 2001). The enzyme existed as a tetramer in 
solution. The enzyme catalyzes the cleavage of P-carotene and P-cryptoxanthin, but not of 
zeaxanthin or lycopene. This substrate specificity suggested that at least one unsubstituted p-
ionone ring half-site was necessary for efficient cleavage of the carbon 15,15'-double bond in 
carotenoid substrates. The enzyme shows a 4-fold higher Km when P-cryptoxanthin was 
used as substrate as compared with p-carotene. Alignment of the amino acid sequences 
showed that about 8% of the highly hydrophobic amino acids were conserved, and these 
residues might participate in the formation of the substrate-binding pocket. The enzyme was 
shown to be sensitive to micromolar concentrations of the metal chelating agents a,a-
bipyridyl and o-phenanthroline, confirming its dependence on iron. High levels of mRNA 
were observed along the whole intestinal tract, in the liver, and in the kidney, whereas lower 
levels were present in the prostate, testis, ovary and skeletal muscle. The expression of the 
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P,|3-carotene 15,15'-monooxygenase gene in nondigestive tissues suggest this enzyme may 
also play a role in peripheral vitamin A synthesis for plasma-bome provitamin A carotenoids. 
Summary 
Fifty years after its discovery, new perspectives have been opened for understanding 
of the molecular structure and mechanism of the enzyme that cleaves P-carotene, due to the 
cloning and characterization of P,P-carotene 15,15'-monooxygenase in various species. 
There are differences in gene sequences for this enzyme in different species, but some amino 
acids are highly conservative. In general, p,P-carotene 15,15'-monooxygenase is a protein 
with about 560 amino acids and a calculated molecular mass of about 64 kDa. Its activity is 
iron-dependent. It has selectivity on substrates and only cleaves at the 15,15'-double bond 
when the substrate has at least one unsubstituted p-ionone ring. Eccentric cleavage of P-
carotene is catalyzed by a different enzyme. Application of the cloned and purified P-
carotene cleavage enzymes will help answer some fundamental questions at a new level in 
carotenoid and vitamin A research. 
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Table 1 Stable isotope tracer methods for study of P-carotene absorption and conversion 
References Subjects Doses Fat 
contents 
Analytical Methods Results/Conclusions 
Dueker 
et al 2001 
Dueker 
et al. 1994 
Dueker 
et al. 1998 
One 
35-y 
non­
smoking 
male 
One 
53-y 
non­
smoking 
male 
One 
22-y 
female 
14, C-P-carotene, 
306 ng (200nci) 
P-carotene-dg, 
73 pmol 
P-carotene-dg, 
56 pmol 
25g 
total 
2g 
N/A 
Accelerator mass 
spectrometry (AMS) 
Tandem mass spectrometry 
(MS/MS) with electron 
ionization and HPLC 
Selected ion storage-ion trap 
mass spectrometry (SIS-
ITMS) 
* Absorption rate: 46.2% of dose 
""Conversion rate: 62% of the 
absorbed dose 
*Tum-over time: 58 days for 
P-carotene and 209 days for retinal 
Establishing a feasible method for 
investigation of absorption and 
metabolism of P-carotene-dg 
in humans 
SIS-ITMS approach expands the 
scope of vitamin A/p-carotene 
kinetic studies by permitting the 
reliable quantitation of labeled 
vitamin A at low enrichment 
Lin et al. 2000 11 
healthy 
female 
30 |imol D& 
retinyl acetate; 
37^mol Da 
P-carotene 
16g Double-tracer; SIS-GC-MS 
total for retinal and reversed phase 
HPLC for P-carotene 
* Absorption rate of Da P-carotene: 
3.3 ± 1.3% (6 subjects: 6.1 ± 
0.02%; 5 subjects: ^ 0.01%) 
*Conversion rate: 0.811 ± 0.343 
mol D; ROL: Imol De-P-carotene 
(6 subjects: 1.47 ± 0.49 mol:l; 5 
subjects: 0.014 ± 0.004:1) 
(Continued) 
Table 1 (Continued) 
References Subjects Doses Fat Analytical Methods Results/Conclusions 
contents 
Hickenbottom 11 
et al. 2002 healthy 
male 
Hickenbottom One 
et al. 2002 male 
subject 
30 pmol D@ 
retinyl acetate, 
37|imol Dg 
P-carotene 
30 pmol Dg 
retinyl acetate, 
30 |imol Da 
p-carotene, 
0.27 |imol "C 
P-carotene 
16 g 
total 
16 g 
total 
Double-tracer; SIS-GC-MS 
for retinal and reversed phase 
HPLC for P-carotene 
Double-tracer; SIS-GC-MS 
for retinal and reversed phase 
HPLC for P-carotene, AMS 
fbr"C 
* Absorption rate of Da P-carotene: 
2.2 ± 0.9% (6 subjects: 4.1 ± 
1.21%; 5 subjects: 0.0003 ± 
0.0002%) 
""Conversion rate: 0.029 ± 0.0108 
mol D; ROL: Imol Da-P-carotene 
(6 subjects: 0.0540 ± 0.0128 
mol:l; 5 subjects: 0.0003± 
0.0002:1) 
Conversion rate: 8.5 mol of 
P-carotene : 1 mol retinoL, 
Absorption rate: 55% of the dose 
(Continued) 
Table 1 (Continued) 
References Subjects Doses Fat 
contents 
Analytical Methods Results/Conclusions 
Tang et al.2000 One 1) 234.7 |imol 1)32 g Stable isotope reference * Conversion rate: 
female P-carotene-dg, total method; 1)55:1 
2) 11.2 pmol 2) 30.5 g Electron capture negative 2)3.8:1 
(3-carotene-dg, total chemical ionization 
(two doses are 5- 3) 0.5g 
y apart) total 
3) Reference 
dose: 30.6 pmol 
retinyl-acetate-dg, 
(taken between 
two doses) 
Tang et al 2003 10 men, 6 mg B-carotene- 13.5 g, Stable isotope reference "Conversion factor 9.1:1 by 
12 dg 25% of method; weight or 4.8:1 by mol (range: 
women 3 mg retinyl- energy LC-atmospheric pressure 2.4-20.2) 
acetate-dg chemical ionization-MS for *Conversion factor positively 
(reference dose) P-carotene correlated with BMI 
GC-electron capture negative 
chemical ionization-MS for 
retinol 
(Continued) 
Table 1 (Continued) 
References Subjects Doses Fat Analytical Methods Results/Conclusions 
contents 
Tang et al. 
1997 
One 
female 
235 |imol 
P-carotene-dg 
32g 
total 
1 Flow-injection atmospheric 
pressure chemical ionization-
mass spectrometry 
(FI/APCI-MS) for 
P-carotene-dg absorption 
2. Gas chromatography-mass 
spectrometry with electron 
capture negative chemical 
ionization (GC/EC-NCI-MS) 
for conversion of 
P-carotene-dg to retinal-d* 
"Method development 
Edwards et al. 
2001 
3 adults 11.2 nmol 
P-carotene, from 
carrot or spinach; 
6.0 |imol Retinyl 
acetate-d* 
20g 
total 
Postprandial chylomicron 
approach using retinyl-
acetate-d4 as extrinsic 
reference; GC-MS and 
HPLC 
"Absorption rate: 2.9% of dose 
(0.5-7.8%) 
"Conversion rate: 27:1 or 23:1 
(when ignoring the effect of 
a-carotene) 
(Continued) 
Table 1 (Continued) 
References Subjects Doses Fat Analytical Methods 
contents 
Results/Conclusions 
Edwards et al. 
2002 
9 adults 
Parker et al. 
1993 
One 
41-y 
male 
34.7 |imol 
P-carotene from 
carrot puree or 
boiled-mashed 
carrots, or raw 
chopped carrot; 
6 |imol dj-retinyl 
acetate 
1.86 |imol 
perlabeled 
^C-P-carotene 
5g Postprandial chylomicron 
approach using retinyl-
acetate-d4 as extrinsic 
reference; GC-MS and 
HPLC 
20g 
tri-
capnylin 
High precision isotope ratio 
mass spectrometry (gas 
chromatography combustion-
gas isotope ratio mass 
spectrometry (GCC-IRMS) 
"Absorption rate: 2.4 ± 0.81% for 
carrot puree, 0.86 ± 0.59 % for 
mashed carrots, 1.7 ± 1.3% for raw 
carrots 
"Conversion rate: 35:1 for puree 
(4 .6% of ingested P-carotene), 
42:1 for mashed carrots (2.5% of 
ingested P-carotene) 
"Apparent efficiency of 
conversion: 44 ± 11% (24-58%) 
for carrot puree, 59 ± 12% (36-
72%) for boiled-mashed carrots, 
and 63 ± 10% 6>r raw chopped 
carrots 
"A safe and sensitive approach 
which requires only very small 
dose of P-carotene typical or less 
than daily dietary intake 
"Most of the absorbed does was 
converted to vitamin A: 64% as 
retinyl ester, 21% as retinal, and 
14% as intact P-carotene 
(Continued) 
Table 1 
References Subjects Dose Fat 
content 
Analytical Methods Results/Conclusions 
van Lieshout et Indonesia [12,13,14,15,20, 41g Atmospheric pressure "Plateau isotopic enrichment 
al. 2001 children 12',13',14',15',20' total chemical ionization liquid was reached by day 21 
aged 
-^Cio](3-carotene chromatography-mass "The amount of P-carotene in 
8-lly in capsules, spectrometry (APCI LC-MS) oil required to form 1 pg of (n = 35) 80 p.g x 2/d, retinol was 2.4 ng (95% CI: 
7 d/wk, 2 .1,2 .7), with a 
for < 10 wk; ratio of 3:1 for -p-
[8,9,10,11,12,13, carotene in the capsules 
14,15,19,20-
^Ciojretinyl 
palmitate in 
capsules, 
80 |ig x 2/d, 
7 d/wk, 
for ^ 10 wk. 
Pawlosky et al One P-carotene-d8, N/A Liquid chromatography/ Method development 
2000 subject 5mg particle beam-mass Detection limit: 0.6 pmol for 
spectrometry (LC/PB-MS) p-carotene 
Kelm et al One man "C enriched kale N/A Liquid chromatography/ Method development 
2001 particle beam-mass 
spectrometry (LC/PB-MS) 
Table 2. Molecular characterization of P-carotene cleavage enzymes 
References Species 
Molecular 
Characteristics 
Tissue 
Distribution 
Enzymatic 
Activity 
and 
Characteristics 
Cleavage 
Product Homology 
Von Lintig DrasopMb "Protein: "mRNA "Soluble Exclusively * 6.7% overall 
and Vogt me&mogasfer 620 amino acid distribution protein not retinoids sequence identity 
2000 residues, with a restricted tightly to RPE 65 
calculated exclusively to associated to * 5.2% overall 
molecular mass of the head membranes sequence identity 
69.9 kDa. "Enzymatic to VP14 
"Gene: located at activity 
position 87F on dependent on 
chromosome 3. iron 
"Apparent Km 
= 5 pMfbr 
P-carotene 
Wyss et al. Chicken Protein: Primarily in A cytoplasmic Retinal as the High homology to 
2000 526 amino acid duodenum enzyme sole product RPE 65 
residues with a 
calculated 
molecular mass of 
60.3 kDa 
(Continued) 
Table 2 (continued) 
Enzymatic 
Molecular Tissue Activity Cleavage 
References Species Characteristics Distribution and Product Homology 
Characteristics 
Redmond Mouse "Protein: "Liver, kidney, *Km = 6 pM, All frow retinol *70% identity to 
et al 2001 566 amino acid testis and small Vmax = chicken 
residues, with a intestine 36 pmol of *30% identity to 
calculated (highest in retinal/mg/min; Drosophila, 
molecular weight jejunum): * A cytosolic *85% to a 
of 63 kDa 2.4 kb mRNA; enzyme; predicted 
"Conserved "Testis and * Substrate human cDNA, 
histidines and skin: 1.8 kb specificity: low *37% to mouse 
acidic residues mRNA 
*2.4 kb mRNA 
at 7 days post-
conception in 
embryonic 
tissue, declined 
afterwards 
activity towards 
carotenoids 
other than 
(3-carotene 
(including 
lycopene) 
RPE65 
(Continued) 
Table 2 (continued) 
Enzymatic 
Molecular Tissue Activity Cleavage 
References Species Characteristics Distribution and Product Homology 
Characteristics 
Paik et al Mouse Protein: *Most highly in "Apparent Km >90% all-fnzms *48% identity to D. 
2001 566 amino acid the testis, = 0.52-9.5 pM retinal and me&xmogasfgr 
residues, with a followed by for P-carotene, <10% 13-czs *41% identity to rat 
molecular mass of liver and Vmax = 368 retinal and human RPE65 
64 kDa kidney, much pmol/mg/h *85% identity to 
lower in small (23.8-1300) human 
intestine (only "Activity 
the proximal iron-related 
portion of the 
small intestine 
including 
duodenum and 
part of jejunum) 
"During 
embryogenesis: 
highly 
expressed in 
maternal tissue 
but not in 
embryonic 
tissue during 
embryonic days 
7.5 and 8.5 
Table 2 (continued) 
References Species 
Enzymatic 
Molecular Tissue Activity Cleavage 
Characteristics Distribution and Product Homology 
Characteristics 
"Human Protein: "Highly "No enzymatic "Major product: "Human: 68% 
547 amino acid expressed in activity with all-Awis-retinal identity and 80% 
residues, with a RPE (a2.4kb lutein or * Minor similarity with 
calculated transcript) lycopene products: 13-cw Chicken, and 24% 
molecular weight "Lower level in "Activity retinal identity with 
of 62 kDa kidney, significantly Drosophila 
"Human gene: intestine, liver, reduced by the "Mouse: 83% 
- 20 kb, 11 exons brain, stomach addition of identity with human 
and 10 introns, and testis EDTA and 60% with 
mapped to "A soluble chicken 
chromosome protein not 
16q21-q23 associated to 
"Mouse protein: membrane 
566 amino acid 
residues 
Yan et al Human and 
2001 mouse 
Ui 
o 
(Continued) 
Table 2 
Enzymatic 
Molecular Tissue Activity Cleavage 
References Species Characteristics Distribution and Product Homology 
Characteristics 
Lindqvist Human *-64 kDa protein *High levels *No enzymatic *All-(ro?K- *22% protein 
and *8% of the highly along the whole activity with retinol sequence identity to 
Anders son hydrophobic intestinal tract, lutein or the 
2002 amino acids are 
conserved 
liver, kidney 
*Low levels in 
the prostate, 
testis, ovary, 
and skeletal 
muscle 
lycopene 
*4-fbld higher 
Km with 
(3-cryptoxanthin 
than with 
P-carotene 
* A tetramer in 
solutions 
* Sensitive to 
metal chelating 
agents 
*Dependent on 
reduced 
sulfhydryl 
groups for 
maximal 
enzymatic 
activity m v#ro 
protein 
P-Carotene 
,,OH 
Lh N) 
Lutein 
Figure 1. Lutein is a nonpro vitamin A dihydroxy structural analog of ^-carotene. 
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A physiological dose of lutein does not inhibit the bioavailability and bioconversion of 
P-carotene in young women as measured using 
^C tracers and GC-C-IRMS 
A paper to be submitted to the American Journal of Clinical Nutrition 
Xixuan H. Collins, Jeanne W. Stewart, Murray L. Kaplan, and Wendy S. White 
ABSTRACT 
Background: Lutein could be a contributing factor to the low bioavailability and 
bioconversion of P-carotene from dark green leafy vegetables. The high sensitivity of gas 
chromatography-combustion interfaced-isotope ratio mass spectrometry (GC-C-IRMS) 
makes it possible to administer ^C-labeled tracer doses of p-carotene and lutein at levels 
typical of dietary intake and to follow the fate of these carotenoids after their administration. 
Objective: We compared in female subjects the appearance of ^C-P-carotene and its 
cleavage product, ^C-retinol, in the plasma after ingestion of a 1-mg dose of ^C-P-carotene 
with or without a 3-mg dose of ^C-lutein. 
Design: Women (n = 7) each ingested both a single dose and a combined dose in random 
order. Blood samples were collected at selected intervals until 528 h. Lutein, P-carotene, 
and retinol were extracted from saponified plasma and purified by using HPLC. Stable 
isotope ratios of samples were analyzed by using GC-C-IRMS. 
Results: The appearance of ^C-P-carotene in the plasma was not different after ingestion of 
the two doses, nor was the appearance of ^C-retinol. Plasma-P-carotene concentration at 
baseline was negatively correlated with the 0-96 h area under the concentration vs. time 
curve (AUC) for ^C-retinol after the combined dose (r = -0.84, P = 0.02). Plasma lutein 
concentration at baseline was positively correlated with the 0-528 h AUC for '^C-P-carotene 
after the ^C-p-carotene dose alone (r = 0.84, P = 0.02). 
Conclusion: At a level typical of dietary intake and a lutein to P-carotene weight ratio of 3:1 
that is common in vegetables, lutein has no significant effects on the absorption and 
conversion of p-carotene. 
54 
KEY WORDS bioavailability, bio conversion, p-carotene, ^C-tracer, GC-C-IRMS, 
physiological dose, lutein, stable isotope, retinol 
INTRODUCTION 
In developing countries, provitamin A carotenoids in dark green leafy vegetables and 
yellow orange vegetables and fruits account for 70-90% of total vitamin A intake (1). Beta-
carotene is abundant in dark green leafy vegetables but these vegetables are not effective in 
correcting vitamin A deficiency (2, 3). The underlying mechanism may involve an inhibitory 
effect of lutein (P,e-carotene-3,3'-diol), a nonprovitamin A oxycarotenoid and structural 
analog of p-carotene. Lutein is a characteristic matrix component in dark green leafy 
vegetables. The bioavailability of lutein from dark green leafy vegetables is considerably 
higher than that of P-carotene (4). In one study (5), 69 volunteers consumed meals with 
different vegetables. Consumption of a lutein-rich spinach meal did not increase plasma P-
carotene concentrations, whereas consumption of meals with broccoli and green pea 
introduced significant increase in plasma P-carotene level, despite the much higher (10-fbld) 
P-carotene content in the spinach meal than that in the broccoli and green pea meals (5). In 
another recent study involving 77 Indonesian children, the bioefRcacy and bioavailability of 
P-carotene in pumpkin were both 1.7 times that of p-carotene in spinach (6). There is a need 
to identify the matrix component in dark green leafy vegetables that restricts the absorption 
and conversion of p-carotene to vitamin A. This study focused on lutein as the candidate 
matrix component because a high lutein content could adversely affect the bioavailability of 
P-carotene in spinach and other dark green leafy vegetables by having a competitive or 
antagonistic effect on the intestinal absorption of P-carotene (7; 8), and/or by inhibiting the 
cleavage of P-carotene to vitamin A (9). 
In this study, gas chromatography-combustion interfaced-isotope ratio mass 
spectrometry (GCC-IRMS) and highly-enriched (>95% ^C) ^C-labeled tracer doses of P-
carotene and lutein (10-12) were used. By using this approach, we had the analytical 
sensitivity to employ small, physiological tracer doses of p-carotene and lutein, and the 
specificity to quantify the bioconversion of newly absorbed P-carotene to retinyl esters. 
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Studies conducted without benefit of stable isotope tracers have had inconsistent findings as 
to whether lutein inhibits the intestinal absorption and/or cleavage of P-carotene in humans 
(7, 8). In these studies, P-carotene and lutein were ingested in doses that greatly exceed 
effective (absorbed) doses typically derived from fruits and vegetables (13). The equimolar 
doses of p-carotene and lutein that were administered do not extrapolate to the 
disproportionate content of lutein in dark green leaves. Use of small physiological doses of 
P-carotene in this project has the advantages of avoiding down-regulation of P-carotene 
15,15'-monooxygenase activity (14, 15), and specifically detecting retinoid metabolites of the 
ingested p-carotene tracer. The high-sensitivity tracer detection provided by gas 
chromatography-combustion interfaced-isotope ratio mass spectrometry (GC-C-IRMS) is 
uniquely suited to accomplish our research objectives. 
SUBJECTS AND METHODS 
Subjects 
Healthy Caucasian women (n = 7), aged 20-31 y, were selected based on interview, 
physical examination, and complete blood count and blood biochemistry profile according to 
our established protocols (12, 16, 17). Criteria for exclusion were current or recent cigarette 
smoking, chronic disease, lipid malabsorption or gastrointestinal disorders, lactose 
intolerance, vegetarianism, hyper lip idemia confirmed by blood lipid profile, history of 
anemia and excessive bleeding, pregnancy, use of oral contraceptive agents or contraceptive 
implants, use of medications that may affect lipid absorption or transport (including 
antibiotics), use of vitamin or mineral supplements, and frequent consumption of alcoholic 
beverages (>1 drink per day). The characteristics of the subjects are presented in Table 1. 
Informed consent was obtained from all subjects, and the study protocol was approved by the 
Human Subjects Review Committee of Iowa State University. 
Treatments 
In a crossover design, subjects were assigned to two treatments in random order. For 
the single-dose treatment, subjects consumed a tracer dose of 1 mg (1.7 |imol) of ^C-P-
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carotene. For the mixed-dose treatment subjects consumed a combined dose of 1 mg of ^C-
P-carotene and 3 mg (5.3 pmol) of ^C-lutein. The test doses were ingested in random order 
and were separated by a washout period of > 4 wk. 
Experimental Diets 
Subjects were provided a list of carotenoid-rich Suits and vegetables and vitamin A-
rich foods and were instructed to avoid consumption of those foods for 4 days before the 
beginning of each of the 2 study periods. During the study periods, subjects consumed a 
controlled low-carotenoid, low-vitamin A diet of conventional foods for 2 days before and 4 
days after dosing. A single daily menu of weighed food portions was provided. The meals 
were prepared and consumed in the Human Nutrition Metabolic Unit of the Center for 
Designing Foods to Improve Nutrition at Iowa State University, except for the carry-out 
lunches and evening snacks on weekdays. Adherence to the experimental diet was monitored 
by written self-report and by analysis of fasting plasma carotenoid concentrations using high-
performance liquid chromatography (HPLC). Duplicate aliquots of 24-h diet composites 
from each of the two study periods were analyzed for carotenoid content. The extraction of 
the carotenoids followed the protocol described previously (18). On average, across two 
study periods, the daily diet provided (mean ± S EM): 6.2 ±0.1 pg lutein, 7.5 ± 0.4 pg P-
carotene, 0.8 ± 0.1 pg retinol, and no detectable a-carotene, P-cryptoxanthin, or lycopene. 
The macronutrient composition of the diet was estimated using Nutrition Data System for 
Research, Version v4.03/31 (N-Squared Computing Inc., Salem, OR). The daily diet of 9.7 
MJ was distributed as 14% of total energy from protein, 59% of total energy from 
carbohydrate, and 27% of total energy from fat. 
Preparation of biosynthetic '^C-labeled tracers 
Autotrophic algae grown with ^COg as sole carbon source were previously used to 
economically produce per-labeled (>98% ^C) P-carotene (10, 11) and per-labeled (>99% 
^C) lutein (12) for use as stable isotopic tracers. In this study, ^C-p-carotene was isolated 
from a crude lipid extract of the saponifiable fraction of Dzma/W/a sp. as a contaminant from 
the nonsaponifiable fraction. ^C-Lutein was isolated from a commercially-available 
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(Martek, Columbia, MD) crude lipid extract of the nonsaponifiable faction of CA/ore/Za sp. 
All solvents were HPLC grade, and were purchased from Fisher Scientific (Chicago, IL). 
To isolate ^C-P-carotene, the saponifiable fraction (50 mg) was extracted repeatedly 
with 15 mL of a mixture of hexane/ethyl ether (2:1, vol:vol) until the residue was almost 
colorless. The combined hexane/ethyl ether layers were evaporated to dryness vocwo. 
Methanol (5 mL) was added to the residue to dissolve lutein and other xanthophylls but to 
sparingly dissolve P-carotene (19), which was then isolated by filtration. During the 
filtration step, the yellow residue on the filter paper was washed twice with 5 mL of 
methanol to remove residual tracers of lutein and other xanthophylls. The p-carotene was 
then further purified from the yellow residue by crystallization. The yellow residue was 
dissolved in a minimal amount (4 mL) of warm (40°C) methanol/water (90:10, vol:vol) 
solution and stored under argon overnight at -20°C to allow crystallization. The P-carotene 
crystals in methanol/water solution were filtered and washed with methanol (50 mL). 
A modified solvent partitioning method based on a protocol established in our 
laboratory (12) was used to purify per-labeled ^C-lutein. A portion of the crude algal extract 
(150-200 mg) was added to a 50-mL culture tube with a screwcap. Acetone (25 mL) was 
added to the crude extract and vortexed for 2 min. The mixture was centrifuged at 1380 x g 
for 10 min and the acetone layer was removed. This procedure was repeated 3 times and the 
combined acetone layers were concentrated under argon to a volume of about 50 mL. Ten 
milliliters of the concentrated acetone solution were partitioned with hexane (1:1, vol: vol) 
and an equal volume of water. The mixture of acetone and water was discarded and the 
hexane fraction was saved and combined and washed with an equal volume of water. An 
equal volume of a methanol-water mixture (95:5, vol:vol) was added to the hexane fraction 
carefully in a separation funnel, without shaking to avoid formation of an emulsion, and the 
methanol layer was saved. The methanol fraction was further partitioned by adding an equal 
volume of ethyl ether. Water was added until two layers were formed. The methanol and 
water layer was discarded and the ethyl ether layer was transferred to a 50-mL tube with a 
screwcap. The ethyl ether layer was washed with water to remove the methanol residue, and 
then dried m vacuo. The dried product was dissolved in 4 mL hexane, vortexed, and filtered 
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(MSI MAGNA nylon disc 6Iter, 0.22 pm, Micron Separations Inc, Westboro, MA.). The 
filtrate was washed with 100 mL cold hexane. 
The crude lutein product was further purified from the yellow residue by 
crystallization. The yellow residue was dissolved in 1-2 mL of warm (40°C) methanol, and 
an equal volume of hexane was added drop-wise after the methanol was cooled to room 
temperature. The mixture was then stored in the dark, under argon, at -20°C overnight for 
crystallization. The lutein crystals were filtered and washed with 50 mL cold hexane. The 
final product was left in the dark in a hood for 8 hours to completely evaporate the solvent. 
The tracers were stored under argon in the dark, at -80°C. 
The purity of the ^C-P-carotene tracer was estimated to be 91% on the basis of peak 
area using HPLC analysis with photodiode array detection; the contaminants were 
unidentified but there were not detectable lutein or zeaxanthin (Figure 1A). The estimated 
purity of ^C-lutein tracer was 96%; the contaminant was 4% zeaxanthin and there was no 
detectable p-carotene (Figure IB). The retention times and ultraviolet/visible absorbance 
spectra of ^C-p-carotene (Figure 2) and ^C-lutein (Figure 3) tracers were identical to those 
of commercial P-carotene (Sigma Scientific, St Louis, MO) and lutein (Kemin Industries, 
Des Moines, IA) standards. The ^C enrichment of P-carotene was ^ 96.5% and the ^C 
enrichment of lutein was > 100%, as determined by using serial dilution with unlabeled P-
carotene (Sigma Scientific, St. Louis, MO) and lutein (Kemin Industries, Des Moines, IA) 
and stable carbon isotope-ratio analysis by GC-C-IRMS. Confirmatory mass spectra of the 
purified ^C-p-carotene and '^C-lutein (Figure 4) were obtained using a Finnigan (currently 
Thermoquest, San Jose, CA) TSQ 700 triple quadrupole mass spectrometer in electron 
ionization mode (70 ev) and were compared with those of standards. The sample was 
introduced into the ion source by direct insertion of probe at 200°C. Mass spectra were 
acquired over the range m/z 100-800 in 0.75 s. 
The doses were prepared as previously described (10, 12) with slight modification. 
Specifically, P-carotene or P-carotene and lutein were solubilized in 28 g of high-oleic acid 
sunflower oil (Abitec Co., Janesville, WI) and emulsified using a hand-held mixer with a 
puree of 30 g of banana and 70 mL of nonvitamin-fbrtified nonfat milk (generously donated 
by Anderson Erickson Dairy Co., Des Moines, IA). The original vial and the mixture were 
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then rinsed with 30 mL of nonvitamin A-fortified nonfat milk, which was added to the 
emulsion. After drinking the emulsion, the subjects were instructed to rinse the container 
with 50 mL of nonvitamin-fortified nonfat milk and consume the rinse. The subjects 
consumed 94 g of plain bagel immediately after ingestion of the dose. 
Study protocol 
On the morning of the third day of the low-carotenoid low-vitamin A diet, subjects 
arrived at the metabolic unit after an overnight (12-h) fast. A baseline blood sample (21 mL) 
was drawn via a catheter placed in a forearm vein by a registered nurse. After ingestion of 
the dose, blood samples (14 mL) were drawn at hourly intervals for 12 h via the intravenous 
catheter into a syringe and transferred to tubes containing heparin as anticoagulant. The 
patency of the catheter was maintained by flushing with sterile physiological saline, as 
previously described (12, 16,17). During the period of hourly blood collection, subjects 
continued the low-carotenoid, low vitamin A experimental diet, including a breakfast 
ingested with the ^C-tracer dose, a lunch ingested immediately after the 5-h blood draw, and 
an evening meal ingested immediately after the 10-h blood draw. Additional blood samples 
were drawn from the antecubital vein via venipuncture at 16 h and aAer an overnight (12-h) 
fast at 24,48, 72, 96, 192, 360, and 528 h. Blood samples were immediately placed on ice 
and protected from light. Plasma was separated by centrifugation (1380 x g, 4°C, 20 min) 
and stored at -80°C in the dark until analyzed. 
Purification of plasma p-carotene, lutein and retinol fractions 
Beta-carotene, lutein and retinol were purified from individual plasma samples. 
Samples were not duplicated due to the large volume of plasma needed in order to extract 
enough analytes that have sufficient masses to be analyzed using GC-C-IRMS. We could not 
draw more than 14 ml of plasma from each subject at each time point from 1 h until 12 h post 
dosing, due to the close interval (1 h) between each blood draw. Plasma samples (4 mL) 
were divided into four 1.0-mL aliquots to ensure efficient extraction. The samples were 
deproteinized with 1 mL of ethanol containing 0.1g/L butylated hydroxytohiene, and 
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extracted twice with 8 mL of hexane containing O.lg/L butylated hydroxytoluene. The 
combined hexane layers were evaporated to dryness under vacuum. A saponification step 
was needed to remove lipids that would otherwise interfere with the gas-liquid 
chromatographic separation of the major products of derivatization of lutein and P-carotene 
before elution into the combustion interface of the GC-C-IRMS. The dried hexane extracts 
were dissolved in 0.5 mL of ethanol containing 0.1g/L butylated hydroxytoluene in a 4-mL 
screw-capped vial. Another 0.5 mL of ethanol containing 5.5 mM pyrogallol was added to 
the vial followed by 1.0 mL of 5.3 M aqueous potassium hydroxide. The vial was filled with 
argon and the contents were mixed by vortexing for 1 minute. The samples were saponified 
at 65°C for 60 minutes in the dark with shaking. After cooling the saponified samples to 
room temperature over ice, the contents were transferred to a glass culture tube (16 x 100 
mm) and extracted twice with 8 mL of hexane containing 0.1 g/L of butylated 
hydroxytoluene. The combined extracts were washed twice with 5.0 mL of HPLC grade 
water. Commercially available unlabeled P-carotene standard (Sigma, St. Louis, MO) and 
lutein standard (generously donated by Kemin Industries Inc, Des Moines, IA) were added to 
the extracts as carriers to ensure sufficient mass to be analyzed by GC-C-IRMS. The 
unlabeled standards also diluted the ^C concentrations of the analytes so that they could be 
measured with high precision within the linear range of GC-C-IRMS (20). The accurate 
amounts of the added standards were recorded each time (P-carotene: - 3.4 nmol, and lutein: 
- 4.7 nmol) and used for back-calculation of the enrichment of the samples. The stable 
carbon isotope ratio (expressed as Atom Percent vs. the international standard PDB) was 
1.08246 for unlabeled p-carotene standard and 1.07710 for unlabeled lutein standard, as 
measured without derivatization by using a NA 1500 elemental analyzer (EA) (CE Elantech, 
Lakewood, NJ) interfaced to the Optima isotope ratio mass spectrometer. Lutein and P-
carotene were quantitatively combusted to CO: and %0; H%0 vapor was removed by a 
chemical trap, and CO2 was further purified by GC on a Poropak QS column (2 m x 4 mm 
i.d.) and administered into the Fisons/VG Isotech Optima IRMS (currently Micromass UK, 
Manchester, UK). 
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The combined hexane extracts and added p-carotene and lutein standards were dried 
under vacuum using a SpeedVac Concentrator (Savant, Farmingdale, NY) in preparation for 
isolation of retinol, p-carotene and lutein fractions by HPLC. 
The dried residue was dissolved in 50 pL of ethyl ether and 200 pL of methanol with 
Ig/L ammonium acetate (mobile phase A) and a 245-pL aliquot was injected into the HPLC 
system. The components of the HPLC system were manufactured by Waters 
Chromatography (Milfbrd MA) and consisted of the 717Plus autosampler with temperature 
control set at 5°C, two 510 solvent delivery systems, and the 996 photodiode array detector. 
The system operated with Millennium^ Chromatography Manager software. Solvents were 
HPLC grade: methanol, methyl /erf-butyl ether (MTBE), and ammonium acetate were 
purchased from Fisher Scientific (Chicago, IL). The mobile phase was filtered (nylon 
membrane filter, 0.2 pm, Whatman International Ltd., Maidstone, England) and degassed 
before use. A 5-pm C30 Carotenoid Column (YMC Inc, Wilmington NC, now Waters Co., 
Milfbrd MA) (4.6 x 250 mm) protected by a precolumn packed with the same stationary 
phase was used to achieve baseline resolution of lutein and the constitutional isomer, 
zeaxanthin. Carotenoids were eluted by using a linear mobile phase gradient from 100% 
methanol (with Ig/L ammonium acetate) to 100% MTBE over 30 min, as modified from 
Sander et al (1994) (21) and Yao et al (2000) (12). The flow rate was 1.0 mL/min. Elution 
of plasma carotenoids were monitored at 453 nm and elution of retinol was monitored at 325 
nm The fractions of retinol, p-carotene and lutein were collected, dried under vacuum, and 
re-dissolved in 50 pL of ethyl ether and 150 pL of methanol (with Ig/L ammonium acetate) 
and re-purified by injecting 195 pL into the HPLC system, using the same reversed-phase 
HPLC conditions. Before the second purification, the C30 column was washed with a 
mixture of mobile phase A (methanol with Ig/L ammonium acetate) and 2-propanol (1:1, 
vol:vol) for 20 minutes with a flow rate of 1 mL/min to minimize the lipid residues left in the 
column from the initial HPLC purification (22). During the second purification, the retinol 
fraction was collected, and 100 pL of methanol with Ig/L butylated hydroxytoluene was 
added (23). The retinol fraction was then stored under argon in the dark at -20°C until 
further purification with a normal phase HPLC column before being injected into GC-C 
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IRMS. The P-carotene and lutein fractions were immediately derivatized for GC-C-IRMS 
analysis. 
The retinol fractions were dried under vacuum, reconstituted with 50 p,L of ethyl 
ether and 150 pL of isooctane/ethanol (95:5, vol/vol), and a 195-pL aliquot was injected into 
a Betasil Cyano analytical column (Keystone Scientific, Bellefbnte, PA) (4.6 x 150 mm) and 
eluted using an isocratic mobile phase of isooctane/ethanol (95:5, vol/vol). The flow rate 
was 1.0 mL/min. The retinol fraction was collected and dried under vacuum and 
immediately injected into GC-C-IRMS. 
To ensure that there was no carry-over of ^C in the HPLC system after purification 
of samples that could be highly enriched, samples from an unlabeled plasma pool were 
periodically purified with the same HPLC procedures, derivatized (as follows), and analyzed 
with GC-C-IRMS. The results showed that there was no ^C contamination in the HPLC 
column. 
Derivatization of P-carotene and lutein for GC-C-IRMS analysis 
The conjugated polyene system of carotenoids is thermally labile, therefore the 
alcohol hydrogenolysis and hydrogénation of lutein (12) and hydrogénation of p-carotene to 
produce a thermally stable analog (10, 11) were necessary prior to stable carbon isotope 
analysis by using GC-C-IRMS. Platinum oxide was used as catalyst for hydrogénation of p-
carotene and palladium on carbon (5 wt%) was used for lutein (12). The catalysts were 
purchased from Alfa Aesar (Ward Hill, MA). The hydrogénation tubes were filled with 
argon, and the catalysts (1 mg of platinum oxide or 10 mg of palladium on carbon) were 
promptly added to the tubes, followed by addition of 0.5 mL of HPLC-grade cyclohexane 
and 0.5 mL of glacial acetate acid containing 0.02 M /)-toluenesulfbnic acid monohydrate 
(Aldrich, Milwaukee, WI). The catalysts were then reduced by hydrogénation for at least 30 
min prior to addition of the dried, purified p-carotene and lutein fractions that were 
suspended in 250 |iL of cyclohexane. The reaction proceeded at 60°C and under 12 psi 
hydrogen pressure with agitation generated by a micro stir bar for 16 hours. The reaction 
products were washed with 2 mL of HPLC-grade water and extracted twice with 6 mL of 
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hexane. The combined hexane layers were washed twice with 4 mL of HPLC-grade water, 
dried under vacuum, and stored under argon at -20°C until analyzed by using GC-C-IRMS. 
Hydrogénation of P-carotene and hydrogenolysis and hydrogénation of lutein yielded the 
same major product, perhydro-(3-carotene. Confirmatory mass spectra of perhydro-P-
carotene derived from plasma p-carotene and lutein (Figure 5) were obtained using a 
Finnigan TSQ 700 triple quadrupole mass spectrometer in electron ionization mode (70 ev). 
GC-C-IRMS analysis 
The stable carbon isotope ratios of retinol and the perhydro-(3-carotene were 
determined by using a 5 890A Hewlett-Packard (Wilmington, DE) GC fitted with a 
Fisons/VG Isotech Isochrom GC-combustion interface to the Fison/VG Isotech Optima 
IRMS. A 15 m x 0.25 mm i.d. (0.25 ^m film thickness) HP-IMS (J & W Scientific, Folsom, 
CA) fused-silica capillary column with on-column injector was used with ukrapure helium as 
carrier gas at a flow rate of 40 cm/s. The temperature program proceeded from 50°C 
followed by a gradient of 30°C/min to 150°C followed by a gradient of 15°C/min to 300°C 
and a 22-min hold at 300°C. The computer-generated stable carbon isotope ratio 
measurements, expressed in delta (6) per mil (part per thousand, %o) units, were used to 
calculate the atom percent ^C in each plasma retinol sample according to the Allowing 
formula: 
(100 x RpoB) x (8^C/1000 + 1) 
Atom% 13C = 
1 + (RW x (6^C/1000 + 1) [1] 
in which Rpos represents the ^C/^C ratio for the international standard for carbon, Pee Dee 
Belemnite (PDB), with an accepted value Rpos = 0.0112372 (13). 
The atom percent (AP) values of P-carotene and lutein in samples were calculated 
based on the following mass balance equation (20): 
Fm = (n/nm)F + (n,/nm)Fi [2] 
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and AP = 100 % F (in %) [3] 
in which n is the amount of the unlabeled material; n, is the amount of labeled material; nm is 
the final amount of the mixture (n, + n). F is the atom fraction of unlabeled material, as 
determined by directly analyzing the isotopic composition of unlabeled ^-carotene and lutein 
standards without hydrogénation by using EA (see above). The F value was 0.0108246 for 
P-carotene standard and 0.010771 for lutein. Fm is the atom fraction of the mixtures (plasma 
P-carotene or lutein plus added unlabeled P-carotene or lutein standards), as measured by 
using GC-C-IRMS. 
For each subject, the atom percent excess (APE) ^C in plasma P-carotene, lutein and 
retinol at each time point was calculated by subtraction of the atom percent ^C in plasma P-
carotene, lutein and retinol at baseline from that in plasma P-carotene, lutein, and retinol after 
ingestion of the ^C-P-carotene and ^C-lutein tracers. The APE controls for variation in 
natural abundance and reflects the percentage of total plasma p-carotene and lutein that is 
^C-labeled, and the conversion product of the ^C-P-carotene to retinol after ingestion of the 
^C tracers (11). 
Calculation of "C-p-carotene, lutein and retinol in plasma 
The plasma concentrations of ^C-P-carotene, lutein and retinol were calculated from 
the total (labeled plus unlabeled) plasma concentrations determined by using HPLC and the 
APE ^C in the plasma fractions determined by using GC-C-IRMS. In order to measure the 
total plasma concentrations, duplicate 200-^L aliquots of plasma were deproteinized by 
adding an equal volume of absolute ethanol containing 0.1g/L butylated hydroxytohiene and 
echinenone (Carotenature GMBH, Lupsingen, Switzerland) as an internal standard. Samples 
were then extracted twice with 4 mL hexane containing 0.1 g/L butylated hydroxytohiene, 
and the combined hexane layers were evaporated to dryness under vacuum. The residues 
were reconstituted with 50 ethyl ether and 150 |iL methanol (with Ig/L ammonium 
acetate), and 50 pL aliquots were injected into the HPLC system. The reversed-phase HPLC 
conditions were as previously described for the purification of P-carotene, lutein and retinol 
fractions. Calibration curves were generated from the ratio of the peak area of the standards 
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to that of the echinenone internal standard plotted against the injected amounts of the 
standards. Analyses were performed under yellow light. A quality control sample from an 
unlabeled plasma pool was analyzed daily by using HPLC to ensure the accuracy and 
reproducibility of the analyses. The inter-assay coefficient of variance (CV) for retinol, (3-
carotene, and lutein in the pooled plasma samples were 4.3%, 4.4% and 1.0%, respectively. 
The plasma concentrations of ^C-p-carotene, lutein and retinol were calculated as the 
product of the total plasma concentrations determined by using HPLC and the atom fraction 
excess of ^C in dose, using the following formula (24): 
(Total concentration of X)(APE^C in X) 
100 ( fraction excess IJC in dose) (4) 
in which the fraction excess is 0.965 for ^C P-carotene and 1.00 for ^C-lutein as 
determined by using serial dilution with unlabeled p-carotene and lutein, and stable carbon 
isotope-ratio analysis by GC-C-IRMS (see above). Since plasma ^C-retinol originates solely 
from the ^C-P-carotene dose, 0.965 was used to calculate the plasma concentration of ^C-
retinol. 
Statistical analyses 
The areas under the plasma ^C-P-carotene, lutein and retinol concentrations vs. time 
curves (AUCs) were calculated by using trapezoidal approximation (25). Concentrations of 
total retinol (free retinol and retinyl esters ) were used because saponification of plasma 
samples has hydrolyzed retinyl esters. The time intervals used for AUC calculation were 
chosen based on when the plasma concentrations of ^C analytes came back close to baseline 
after doing; 0-528 h AUCs were calculated for '^C-P-carotene and ^C-lutein, and 0-96 h 
AUC was calculated for ^C-retinol. The ratio of AUCs for ^C-retinol to ^C-P-carotene was 
calculated and used as an index for conversion efficiency (26). 
The effects of treatment on the AUCs for ^C-p-carotene and ^C-retinol for each 
subject were compared using paired student's /-test. The effects of treatment on conversion 
efficiency (ratio of AUCs for ^C-retinol to ^C-P-carotene) were also compared using 
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student's /-test. The plasma appearance and disappearance of ^C-p-carotene and ^C-retinol 
in the presence and absence of lutein were analyzed by repeated measures ANOVA. The 
correlation between AUCs for ^C-(3-carotene, ^C-retinol, and ^C-lutein, and the correlation 
between plasma carotenoid concentrations at baseline and AUCs, were analyzed. A P value 
< 0.05 was regarded as significant. 
RESULTS 
We modified the purification protocol previously developed in our laboratory for 
purification of ^C-hitein tracer from crude algal extract (12). With the old protocol, the 
purity of the lutein tracer was estimated to be 93% on the basis of peak area using HPLC 
analysis with photodiode array detection, and the contaminants were 2% P-carotene and 5% 
zeaxanthin. With the modified protocol, the purity of lutein was estimated to be 96% with 
HPLC analysis, with 4% zeaxanthin as contaminant and no detectable P-carotene. The 
absence of p-carotene contamination in lutein avoided addition of ^C-P-carotene as part of 
the ^C-lutein dose, therefore eliminating the extra ^C-P-carotene as a confounding factor. 
We also modified published protocols for purification of plasma p-carotene and lutein 
(11, 12, 22, 24). By adding a wash step during the HPLC purification procedure, we did not 
need to further purify P-carotene and lutein with a normal phase column after two previous 
reversed-phase HPLC purifications. Therefore the sample preparation procedures were less 
time-consuming which facilitated processing of the large number of samples in the current 
study. This modification also proved to be efficient in reducing sample matrix and 
preventing contamination by plasma lipid, as shown in the GC-C-IRMS chromatograms of 
the derivatized plasma p-carotene (Figure 6) and lutein (Figure 7) products. The plasma 
retinol fraction was also highly pure by using the current purification protocols (Figure 8). 
In these chromatograms (Figure 6, Figure 7, and Figure 8), there is a peak at the end of the 
mass spec program, close to the second sets of CO2 standards. This is not a peak of any 
analyte; instead it was generated when the hot-split (HS) valve was closed at the end of the 
mass spec program, and the gas pressure built up during the mass spec program was carried 
over and released to the flame-ionization detector (FID). 
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The appearance of ^C-p-carotene in the plasma was biphasic after ingestion of both 
doses (Figure 9). After the single dose, there was a smaller peak at 10 h and a bigger peak at 
24 h. AAer the combined dose, the smaller peak appeared at 4 h and the bigger peak at 24 h. 
At 24 h, the concentration of ^C-p-carotene was higher after the ingestion of the 
carotene dose alone as compared with that after ingestion of the combined dose (0.210 ± 
0.039 vs. 0.191 ± 0.023 pmol/L), but the difference was not statistically significant by paired 
student's f-test. Repeated measures ANOVA showed that there was no significant difference 
in the appearance of ^C-P-carotene in the plasma after the two treatments. 
The appearance of ^C-retinol, the product of ^C-P-carotene cleavage, showed three 
concentration peaks (Figure 10). After the single dose, there was a small peak at 5 h, a 
higher peak at 9 h, and the highest peak at 12 h. AAer the combined dose, there was a peak 
at 5 h, 10 h, and 12 h respectively, with the peak at 10 h being the highest and the one at 5 h 
being the lowest. At 5 h and 12 h postdosing, the concentrations of ^Cretinol were higher 
after the ingestion of the '^C-p-carotene dose alone as compared with those after ingestion of 
the combined dose (5h: 0.263 ± 0.060 vs. 0.254 ± 0.035 pmol/L; 12h: 0.446 + 0.047 vs. 
0.431 ± 0.062 pmoI/L), but the differences were not statistically significant by paired 
student's f-tests. The appearance of ^C-retinol did not differ significantly after the two 
treatments, as analyzed using repeated measures ANOVA. 
There was a rapid increase in the appearance of ^C-lutein in the plasma after dosing, 
and it reached a plateau from lOh to 48 h postdosing, with an average value of 25.054 ± 
0.534 pmol/L (range: 23.391 ± 7.146 to 26.682 ± 10.421 pmol/L) (Figure 11). There was 
still detectable amount of ^C-lutein in the plasma at 528 h after dosing, with a value of 2.478 
± 1.504 pmol/L, as compared with 0.408 ± 0.336 pmol/L at 2 h after dosing. The plasma 
area under the concentration-versus-time curve (AUC) values for ^C-lutein for 0-528 h are 
listed in Table 2. 
Plasma area under the concentration-versus-time curve (AUC) values for 0-528 h for 
^C-P-carotene and the within subject difference after ingestion of the ^C-P-carotene dose 
alone and combined dose of '^C-P-carotene and ^C-lutein are shown in Table 3. Paired 
student's f-tests indicate no significant differences between the AUCs for ^C-P-carotene 
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after the single dose and those after the combined dose. Addition of lutein to the dose 
resulted in increased AUC values for p-carotene in three subjects who had lower AUCs (< 30 
pmol - h/L,) after ingestion of the single dose alone, decreased AUC values in three subjects 
who had higher AUCs (> 45 pmol - h/L) after ingestion of the single dose alone, and almost 
no change in one subject (Table 3). 
The AUC values for 0-96 h for ^C-retinol and the within-subject difference are 
shown in Table 4. One subject (subject 3) had a negative AUC value after ingestion of the 
single dose. GC-C-IRMS is very sensitive in measuring small fluctuations of the ^C/^C 
ratio in samples, therefore if the enrichment of a sample is close to the natural abundance, the 
instrument may generate a reading of ^C/^C ratio that is slightly different from the true 
value of the sample due to normal sampling errors. If the measured value is lower than the 
true value, the increment of plasma ^C concentration could be a negative number. The 
negative number can have a large impact on calculation of the AUC if the time interval is 
large, which can result in a negative total AUC. The subject who had the negative AUC had 
negative increment in plasma ^C-retinol concentration over baseline from 48 h to 528 h post 
dosing. This could mean that this subject had '^C-retinol concentrations close to baseline 
from 48 h after dosing, which is different from the rest of the subjects who had plasma ^C-
retinol concentrations approaching to baseline only from 96 h aAer dosing. 
Paired student's f-tests indicate no significant differences between the AUCs for 
^Cretinol after the two doses. Addition of lutein to the dose resulted in reduced AUCs for 
^C-retinol in three subjects, increased AUCs for the other three, and almost no change in one 
subject. Unlike the AUCs for ^C-p-carotene, the AUCs for ^C-retinol after the single dose 
does not seem to predict or related to the AUC values after the combined dose. 
The ratios of AUCs for ^C-retinol to AUCs for ^C-p-carotene are showed in Table 
5, and the comparisons of the appearance of ^C-retinol and ^C-P-carotene are showed in 
Figure 12. The ratio of AUCs for ^C-retinol to AUCs for ^C-P-carotene reflects conversion 
efficiency (26), and the higher the ratio, the higher the conversion efficiency. AAer ingestion 
of the single dose, the subject who had the smallest AUC for ^C-P-carotene showed the 
highest ratio, but the subject who had the highest AUC for ^C-P-carotene did not show the 
lowest ratio. With the exception of one subject (subject 4), the subjects who had higher 
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ratios (> 1) after ingestion of the single dose all had lower ratios after ingestion of the 
combined dose, whereas those who had lower ratios (< I) after the single dose had higher 
ratios after the combined dose (Table 5). Paired student's f-test did not show significant 
differences between the ratios after the two treatments, although the average value of the 
ratio was higher after the single dose (0.52 ± 0.25 vs. 0.29 + 0.13). 
The responses from the subjects to the ^C-P-carotene dose, with or without the 
addition of ^C-lutein, were highly variable. For ^C p-carotene, the interindividual CV for 
0-528 h AUC was 59% (a 2-to 6-fbld difference) after the single dose and 36% (a 1.5- to 2-
fbld difference) after the combined dose. For ^C-retinol, the interindividual CV for 0-96 h 
AUC was 62% (a 1- to 6-fbld difference) after the single dose and 53% (a 1-to 7-fbld) after 
the combined dose. For ^C-lutein, the CV for 0-528 h AUC was 44% (a 3- to 9- fold 
difference). 
There was no correlation between AUC values for p-carotene, retinol, and lutein. 
Plasma concentration of P-carotene at baseline was negatively correlated with the 0-96 h 
AUC for ^C-retinol after the combined dose (r = -0.84, P = 0.02) (Figure 13A). Plasma 
lutein concentration at baseline was positively correlated with the 0-528 h AUC of ^C-p-
carotene after the ^C-P-carotene dose alone (r = 0.84, P = 0.03) (Figure 13B), and positively 
correlated with the 0-528 h AUC of ^C-hitein (r = 0.82, P = 0.02) (Figure 13C). Plasma 
concentration of lutein at baseline was negatively correlated with BMI (r = -0.91, P - 0.004) 
(Figure 13D). 
DISCUSSION 
Parker et al (1993, 1997) first developed the GC-C-IRMS method to study the 
metabolism of a physiological dose of perlabeled ^C-P-carotene in humans (10, 11). Yao et 
al (2000) successfully adapted this approach for the study of another prominent dietary 
carotenoid, lutein (12). The current study is the first to apply this stable isotope tracer 
method to investigate the effects of lutein on the intestinal absorption and bioconversion of 
P-carotene. Lutein and P-carotene were in amounts similar to those typically ingested from a 
single served vegetables (2, 5, 6, 27), and in a lutein to P-carotene ratio typically found in 
dark green leafy vegetables (27-29). The 1 mg of ^C-P-carotene used is similar to the 
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average amount in a single serving of dark green leafy vegetables: 1.0 mg in boiled broccoli, 
0.5 mg in Brussels sprouts, and 5.5 mg in raw spinach (27). The amount is also similar to 
what was used in intervention studies in terms of Retinol Activity Equivalent (RAE) (2, 5, 6). 
The ratio of lutein to P-carotene (3:1) is comparable to the average ratio of lutein to (3-
carotene in various vegetables: 2.5 in cooked kale (27), 4.9 in cassava leaves (28), 2.0 in 
broccoli and spinach (29). Previous studies regarding to the effects of lutein on p-carotene 
absorption and conversion and/or interaction of lutein and P-carotene utilized much higher 
doses of lutein and P-carotene, often as high as 15 mg, which do not reflect our dietary 
intake. A high dose of p-carotene also down-regulates the enzymatic activity of P-carotene 
15,15 '-monooxygenase (14, 15), which is a confounding factor for the study of effects of 
dietary components on p-carotene bioconversion. 
The use of physiological tracer doses was possible due to a metabolic tracer technique 
using highly enriched substrates uniformly labeled with ^C and analysis by high-precision 
GC-C-IRMS (30). GC-C-IRMS combines the advantage of the small sample requirement of 
GC-MS and the high precision of conventional IRMS (12). However it has a limited 
dynamic range over which enrichments can be accurately and precisely measured (20). In 
our study, three Faraday cup detectors continuously monitored ion currents at m/z 44 
(^CO%), 45 (^CO: + ^C^O^O) and 46 (^C^O^O) (12). Amplification of signal at the 
Faraday cups is accomplished by dedicated circuits mounted close to the detectors, and the 
feedback amplifiers are usually highly shielded and are made with high performance resistors 
to yield amplification factors corresponding to the approximate isotopic abundance in nature 
(20). In the case of C isotope ratio, a delta value much above 1000 will compromise 
precision and accuracy, partly due to the large difference between the measured values and 
natural abundance standards (20). In the current study, our samples were highly enriched 
compared with samples with natural abundance, which required caution when measuring 
them with GC-C-IRMS. Brenna et al (1997) suggested two possible solutions to this 
problem: using enriched standards, which still does not eliminate the problem of mismatch in 
amplifications, or coupling a combustion-IRMS system and an ion trap mass spectrometer 
(20). In our case, we applied an economical solution to this problem, by spiking the samples 
with unlabeled commercial P-carotene and lutein standards. We used mass balance (see 
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SUBJECTS AND METHODS), also referred to as the Master Equation, to determine the 
relative contribution of the two carbon sources to the samples: ^C from the tracers and from 
the natural abundance in plasma P-carotene and lutein, and ^C from the plasma p-carotene 
and lutein, and from the added unlabeled standards. The isotopic ratios of baseline samples 
(unenriched) and those of the samples from an unlabeled plasma pool (see SUBJECTS AND 
METHODS) were in the range of natural abundance as measured using GC-C-IRMS, 
indicating no errors were introduce to the calculation of ^C/^C ratios by adding unlabeled 
standards and using mass balance approach. 
The appearance of ^C-P-carotene (Figure 9) in the plasma was biphasic with a 
smaller peak at 10 h aAer the single dose and at 4 h after the combined dose, and a higher, 
broad peak at 24-48 h. The first peak was somewhat delayed aAer the single dose compared 
with previously published data. AAer the single dose, two subjects showed a small peak at 4 
h, three showed a small peak at 5 h, one showed a small peak at 6 h, and one showed a small 
peak at 8 h. Overall there was no distinct peak at 5 h aAer dosing. The small peak at 4 h post 
dosing aAer ingestion of the combined dose, and the second high, broad peak at 24 h aAer 
ingestion of both doses were consistent with previous studies (13, 24), in which there were a 
smaller peak at 5 h and a second, broad peak between 24 and 48h. Our previous studies (16, 
17) and those of others (31, 32) using large, unlabelled doses of P-carotene showed that the 
initial peak coincides with appearance of p-carotene in postprandial triacylglycerol-rich 
lipoproteins (TRLs) and the second peak with the delayed appearance of P-carotene in LDL, 
with the latter reflecting the resecretion of P-carotene from liver. 
The appearance of'^C-retinol, the product of ^C P-carotene cleavage, showed three 
concentration peaks (Figure 10). AAer the single dose, there was a small peak at 5 h, a 
higher peak at 9 h, and the highest peak at 12 h. AAer the combined dose, there was a peak 
at 5 h, 10 h, and 12 h, respectively, with the peak at 10 h being the highest and the one at 5 h 
being the lowest. As the first peak of p-carotene, the first peak of retinol at 5 h coincides 
with the secretion and clearance of chylomicrons, as in the case of dosing with unlabeled P-
carotene (33), which indicates plasma ^C-retinol at 5 h originates from cleavage of ^C-p-
carotene in the enterocytes. Addition of lutein did not affect this process, since there was no 
significant differences in the concentrations of ^C-retinol at 5 h aAer the two treatments, 
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analyzed using paired student's f-test. The appearance of the highest ^C-retinol peaks at 12 
h and 10 h postdosing may suggest that the majority of the cleavage products originate from 
the hepatic cleavage of ^C P-carotene. This is similar to the results in the study by Lin et al., 
in which the plasma D3 retinol concentration peaked at around 10 hours aAer dosing with De 
P-carotene. Addition of lutein did not affect the concentrations of ^C-retinol at 10 h and 12 
h post dosing. 
The mean plasma concentration of ^C-lutein was highest at 16 h (Figure 11), 
consistent with the plasma appearance of ^C-lutein in our previous study (12), as well as the 
results in healthy adults who ingested a single pharmacological dose of unlabeled lutein (7). 
The mean concentrations of'^C-lutein were fairly constant between 10 h and 28 h, ranging 
from 23.4 + 7.2 pmol/L to 26.7 ± 10.4 jimoVL, with almost identical values at 16 h and 48 h 
(26.7 mol vs. 26.4 pmol). This broad plateau in plasma ^C-lutein concentration was not 
reported by Yao et al (12), and it is not clear if it was due to the concurrent ingestion of ^C 
p-carotene and ^C-lutein. 
The responses from the subjects to the ^C p-carotene dose, with or without the 
addition of ^C-lutein, were highly variable. For ^C p-carotene, the intrerindividual CV for 
0-528 h AUC was 59% (a 2-to 6-fbld difference) aAer the single dose and 36% (a 1.5- to 2-
fbld difference) aAer the combined dose. For ^C-retinol, the interindividual CV for 0-96 h 
AUC was 62% (a 1- to 6-fbld difference) aAer the single dose and 53% (a 1- to 7-fbld) aAer 
the combined dose. For ^C-hitein, the CV for 0-528 h AUC was 44% (a 3- to 9- fold 
difference). This result is consistent with previous studies, in which high variability of 
responses to p-carotene doses from different subjects was a commonly observed 
phenomenon. In a group of 79 healthy men, there was a high variability (CV = 61%) of 
response to a 120 mg P-carotene dose, as estimated by the appearance of p-carotene in 
chylomicrons at 3 h postdosing (33). In another study involving 10 male subjects, aAer an 
oral dose of 15 mg of p-carotene, the interindividual variation in the triacyIglycero 1-adjusted 
response of p-carotene in the triacylglycerol-rich lipoprotein (TRL) fraction was 42%, and 
the value for retinyl palmitate was 36% (34). O'Neil and Thumham (1998) also reported 
that, aAer ingesting either 40 mg P-carotene, 31.2 mg lutein or 38 mg lycopene, subjects 
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showed approximately a twofold difference in uptake of P-carotene into the TRL fraction, a 
two- to threefold difference in uptake of lycopene and a two- to threefold variation in uptake 
of lutein (35). In more recent studies using isotopic tracer doses, subjects also showed high 
variability. Lin et al (2000) reported that aAer ingesting 37 |imol De P-carotene and 30 |imol 
De retinyl acetate, only 6 of their 11 female subjects had plasma Dg P-carotene and D3 retinol 
concentrations that could be measured. The remaining 5 subjects were low responders with 
< 0.01% absorption (25). In a separate study with similar design, Hickenbottom et al (2002) 
reported that aAer ingestion of 37 jimol of De P-carotene and 30 p,mol of D& retinol dose, 
only 6 of 11 men had sufficient plasma concentrations of Dg P-carotene and D3 retinol that 
could be measured (36). 
Besides variable responses to a single P-carotene dose, in our study and previous 
studies, subjects also showed different responses to a combined dose of P-carotene and 
another carotenoid. In this study, three subjects had higher values of 0-528 h AUC for ^C p-
carotene aAer the single dose, whereas three subjects had higher values aAer the combined 
dose, and one subject had very similar values aAer the two doses. The same situation was 
true for the values of 0-96 h AUC for ^C-retinol, with three subjects showing larger values 
aAer the single dose and four showing larger values aAer the combined dose. Addition of 
lutein to the P-carotene dose enhanced the plasma AUC for ^C-P-carotene in subjects who 
had lower AUCs for ^C-p-carotene when ingested the single dose, whereas the trend was not 
so clear for AUCs for ^C-retinol. These results were consistent with previous studies (7, 
16). In a study by Kostic et al (1995), 8 subjects were given single P-carotene dose and a 
combined equimolar doses (0.5 pmol/kg body wt) of p-carotene and lutein. In 5 subjects 
lutein decreased the AUC value for P-carotene but enhanced it in three others (7). Paetau et 
al (1997) reported that ingestion of 25 mg canthaxanthin and 25 mg p-carotene resulted in 
decreased plasma AUC for P-carotene in 5 of their 9 subjects, but increased AUC for p-
carotene in the other 3, although overall the AUC values for P-carotene were not different 
with or without canthaxanthin. In contrast, ingestion of the combined dose of P-carotene and 
canthaxanthin resulted in decreased AUC for canthaxanthin in all subjects (16). In these two 
studies, lutein and canthaxanthin enhanced the serum P-carotene AUC of those subjects who 
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had low AUC values aAer ingestion of P-carotene alone, as we have observed in our study 
(Table 3). 
There seems to be no biomarker to predict a subject's response to either a single dose 
of p-carotene or a combined dose of P-carotene and another carotenoid. In women, 
nutritional status, as reflected by baseline plasma P-carotene and vitamin A concentration, 
did not predict a subject's propensity to utilize p-carotene for vitamin A (26); however in 
men, pre-study intake of vitamin A and P-carotene was observed to modulate the response to 
a p-carotene dose (36). Most recently, Lemke et al (2003) reported that vitamin A 
supplementation decreased the cleavage of p-carotene, but increased apparent absorption of 
P-carotene, resulting in larger molar vitamin A values(37). In the current study, the baseline 
lutein concentration was significantly and positively associated with AUC for P-carotene 
aAer the single dose but not aAer the combined dose, and was also significantly and 
positively associated with AUC for lutein. This suggests that subjects with higher baseline 
carotenoid concentrations could be more responsive to supplementation of one carotenoid 
without the presence of a second carotenoid. The plasma concentration of P-carotene at 
baseline was negatively and significantly correlated with 0-96 h AUC for ^C-retinol aAer the 
combined dose (r = -0.84, P = 0.02), but the negative correlation was not significant aAer the 
single dose (r = -0.59, P = 0.16). Although highly speculative, this result could indicate an 
effect of combined doing on the AUC for retinol. The plasma concentration of P-carotene at 
baseline was not correlated with 0-528 h AUC for ^C-P-carotene aAer the single dose (r -
0.11, P = 0.82), or aAer the combined dose (r = 0.45, p = 0.31). 
Studies have reported conflicting results regarding to the relationship between plasma 
carotenoid concentrations and body mass index (BMI). The plasma p-carotene AUC values 
did not correlate significantly with body weight, BMI, fat mass serum cholesterol or 
triacylglycerol, total dietary protein, or fat (25, 33, 35). However, the increase in plasma p-
carotene concentration in response to P-carotene supplementation was significantly and 
inversely correlated with BMI and fat-free mass in older men (38), and significantly and 
inversely correlated with percentage of body fat and fat mass in older women (39). In our 
study and the study by Lin et al (26), subjects were young women (aged 20 to 31 y in our 
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study and 19 to 39 y in their study), and there was no significant correlation between BMI 
and the p-carotene response. This may suggest that age or age-related factors play roles in 
the uptake of p-carotene supplements. There was no significant correlation between BMI 
and conversion ratio (as estimated by the ratio of ^C-retinol AUC to ^C-(3-carotene AUC). 
This is consistent with Lin et al (26) and Hickenbottom et al (35) but different form the 
results from a recent study, in which the conversion of ^Hg-P-carotene to ^-retinol was 
significantly and positively associated with BMI (40). In our study, although BMI is not 
correlated with the response to doses, it is negatively and significantly correlated with the 
baseline concentration of lutein. This result is to some extent consistent with the previous 
studies. In the study by Zhu et al (38), BMI was significantly and negatively correlated with 
baseline plasma total carotenoid concentration. In Yeum's study (39), BMI was significantly 
and negatively associated with baseline plasma concentration of carotenoids in older women, 
but in younger women the negative correlation was only significant between BMI and 
baseline P-carotene. Serum P-carotene concentration and BMI were negatively and 
significantly associated in 276 women (41). Higher BMI values generally mean higher body 
fat percentage (42), and body fat could be a repository or sink for p-carotene, resulting in 
lower serum concentration of P-carotene (40), which could also be true for lutein. 
In our small group of subjects, lutein did not show an inhibitory effect on P-carotene 
absorption and conversion. The lack of improvement of vitamin A status with increased 
consumption of dark-green leafy vegetables (2, 3) despite the abundance of P-carotene in 
these vegetables suggests that some component(s) may inhibit the absorption and conversion 
of p-carotene. Lutein is an obvious candidate because it is another prominent carotenoid in 
these vegetables and even more prominent than P-carotene. Lutein is also a nonprovitamin A 
structural analog to p-carotene, and the structural similarity could interfere with the 
enzymatic activity of p-carotene cleavage enzyme. The hypothesis that lutein inhibits the 
absorption and/or conversion of P-carotene seems to be supported by evidence from in vitro 
studies, and animal data. The bioavailability of lutein from dark green leafy vegetables is 5 
times higher than that of P-carotene (4). Orange fruits, which have little or no lutein, are 
more effective than dark-green, leafy vegetables in increasing serum concentrations of retinol 
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and p-carotene in children with marginal vitamin A status (43). In an in vitro measurement 
of p-carotene cleavage activity, addition of 9 pg of lutein to an incubation of 3 p.g p-carotene 
and cleavage enzyme reduced formation of retinal (9). The deposition of vitamin A in liver 
was significantly decreased in rats fed more lutein (at P-carotene:lutein ratios < 1) (44). 
Recent study from out lab showed that genetic modification of leaves to decrease lutein 
content improves P-carotene utilization in gerbils. Gerbils fed with a vitamin A-free diet 
supplemented with the leaves from a lutein-free (Zw/2) mutant had 48% more 
vitamin A stores in the liver than those fed with a vitamin A-free diet supplemented with the 
leaves from a wild type ofv4ra6%&%ma (45). Lutein was preferentially incorporated into 
chylomicron compared with P-carotene. Gërtner et al (1996) reported that there was a 
preferential increase in chylomicron levels of lutein and zeaxanthin compared with P-
carotene in humans aAer ingestion of a single dose of Betatene, a natural carotenoid source 
that contains 14-fbld higher P-carotene than lutein (46). More recently, Tyssandier et al 
(2002) reported that adding a second carotenoid from a vegetable source to a meal that 
provided a first carotenoid diminished the chylomicron response to the first carotenoid (47). 
Despite all the evidence, human studies using high doses of P-carotene and lutein generated 
inconsistent results as for the interaction of the carotenoids. Kostic et al (1995) reported that 
lutein reduced p-carotene AUC in subjects who had higher AUC value when ingested p-
carotene alone, but enhanced P-carotene AUC in other subjects (7). van den Berg (1998) 
reported that lutein inhibited P-carotene absorption but not conversion, and the inhibitory 
effect of lutein was most marked when lutein was the predominant carotenoid (at a lutein to 
P-carotene ratio of 2:1) (29). In this study we found similar results as reported by Kostic et 
al (1995) (7). Lutein had mixed effects on the AUC value for P-carotene and its cleavage 
product retinol in different subjects. Overall lutein did not affect either P-carotene absorption 
or conversion at a physiological dose and at a 3:1 ratio to P-carotene. Other factors in dark-
green leafy vegetables, such as contents and types of fiber, could be responsible for 
preventing the efficient absorption and/or conversion of P-carotene to vitamin A (48-50). 
Fibers have different effects on the absorption of p-carotene and lutein (48), which may 
partly explain the higher uptake of lutein than P-carotene from vegetables. In our study, we 
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used physiological doses, but both P-carotene and lutein were in their pure forms, not in a 
food matrix. The interaction of P-carotene and lutein could be very different in a food 
matrix. Recently Kelm et al (2001) determined ^C labeled and endogenous p-carotene, 
lutein and vitamin A in a subject who consumed steamed ^C-kale that was grown in a ^CO; 
chamber with > 98% enrichment of ^C in P-carotene and lutein (51). Further investigation 
using stable isotope labeled plant foods may shed light over the question about interaction of 
P-carotene and lutein in a food matrix. 
Simultaneous ingestion of carotenoids may induce an antioxidant-sparing effect in the 
intestinal tract (47, 52, 53), and thus result in increased levels of uptake of the protected 
carotenoids. In the case of P-carotene and lutein, lutein could inhibit P-carotene absorption 
and conversion as shown in in vitro, as well as protect p-carotene as an antioxidant, and the 
overall effect would be a balance between the inhibitory effect and the protective effect. 
Plasma xanthophyll carotenoids have been found to correlate inversely with indices of 
oxidative DMA damage and lipid peroxidation (54). In a carotenoid-containing unilamellar 
liposome model for studying hydrophobic-hydrophilic antioxidant interaction, higher levels 
of p-carotene (>0.02 nmol/mg phospholipid) and lycopene (>0.06 nmol/mg phospholipid) 
exhibited prooxidant effects, whereas lutein inhibited lipid peroxidation in a dose-dependent 
manner between 0.02 and 2.6 nmol/mg phospholipid (55). Lycopene and P-carotene 
degraded more rapidly than lutein and zeaxanthin upon exposure to various pro-oxidants in 
vitro (56). These experimental results suggest that, if lutein does have an antioxidant sparing 
effect to protect p-carotene, this effect could potentially be important. 
The discrepancy between our results and the data from animal studies, in vitro 
studies, and human studies using pharmacological does suggests that non-human, in vitro 
data should not be extrapolated to humans without caution. The study has to be done in 
humans, which makes it important to develop appropriate methods that are not invasive so 
that they can be used in humans, and sensitive enough that can simulate physiological doses 
and dietary intake. The ^C tracer and GC-C-IRMS approach used in this study provides one 
possibility to reach the research goals. 
Plant breeding to enhance nutritional values of plant foods has become a new tool for 
fighting micronutrient malnutrition (57-59). Rice was successfully engineered to produce P-
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carotene in the endosperm (60), and tomatoes that have 1.8-6)Id higher lycopene and 2.2-fbld 
higher P-carotene than wild type have also been produced (61). It will not be surprising if 
high-lutein plants are bred to capitalize upon the putative health benefits of lutein. Our study 
has shown that lutein dose not inhibit bioavailability and bioconversion of p-carotene at a 
normal dietary intake, and this could ease the concerns that high-lutein plant foods could 
potentially impair the utilization of P-carotene. Our finding could also be important 
knowledge base for the supplementation industry for promoting the health benefits of lutein 
without compromising the importance of P-carotene in human nutrition. 
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TABLE 1 
Subject characteristics at baseline* 
Characteristics Value 
"Âge 23.6 + 1.6 (20-31) 
BMI (in kg/nf ) 23.8 ± 1.3 (20.6-28.8) 
Fasting plasma concentrations at baseline (p,mol/L) 
Retinol 1.407 + 0.093 (1.153-1.778) 
p-Carotene 0.222 ± 0.035 (0.105-0.375) 
Lutein 0.165 ± 0.019 (0.103-0.227) 
Zeaxanthin 0.088 + 0.015 (0.000-0.117) 
(3-Cryptoxanthin 0.106 ± 0.018 (0.059-0.178) 
a-Carotene 0.125 ± 0.023 (0.052-0.245) 
Lycopene 0.166 ± 0.032 (0.104-0.351) 
+ SEM with range in parentheses; n = 7. 
TABLE 2 
Area under the plasma concentration versus time curves (AUCs) for ^C-lutein for 0-528 h 
after subjects ingested 1 mg ^C-(3-carotene and 3 mg ^C-lutein 
Subject AUC (pmol h/L) 
Ï 3238.86 
2 5762.88 
3 3979.2 
4 2483.66 
5 5438.15 
6 2014.75 
7 1987.06 
%±SEM 3557.794 + 591.1824 
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TABLES 
Plasma ^C-P-carotene area under the concentration-versus-time curve values for 0-528 h 
aAer subjects ingested 1 mg ^C-P-carotene alone or 1 mg ^C-p-carotene and 3 mg '^C-lutein 
Doses Within-subject 
Subject p-Carotene P-Carotene phis lutein difference 
pmol - h/L 
1 27.778 32.704 -4.926 
2 66.302 52.801 13.502 
3 22.583 61.642 -39.059 
4 46.244 34.609 11.635 
5 71.047 23.643 47.405 
6 26.006 25.096 0.909 
7 11.359 41.632 -30.274 
%±SEM 38.760 ± 8.664 38.875 ±5.341 -0.115 ± 10.946 
TABLE 4 
Plasma ^C-retinol area under the concentration-versus-time curve values for 0-96 h aAer 
subjects ingested 1 mg ^C-P-carotene alone or 1 mg ^C-P-carotene and 3 mg ^C-lutein 
Doses Within-subject 
Subject P-Carotene P-Carotene plus lutein difference 
pmol - h/L 
1 34.416 25.248 9.168 
2 17.029 19.926 -2.897 
3 -0.931 3.275 -4.206 
4 10.467 5.0401 5.427 
5 20.711 21.553 -0.841 
6 15.126 21.728 -6.601 
7 20.879 19.223 1.657 
% ± SEM 16.814 ±4.082 16.570 ± 3.290 0.243 ±2.106 
TABLES 
Area under the plasma concentration-versus-time curve (AUC) values for ^C-P-carotene and ^-retinol and ratio of AUCs for 
^C-P-carotene to AUCs fbr ^C-retinol after subjects ingested 1 mg of ^C-P-camtene with or without 3 mg of ^C-lutein 
13 C-P-Carotene dose ^C-P-Carotene + ^C-Lutein dose 
Subject "C-Retinol ^C-P-Carotene ^C-Retinol : "C-Retinol ^C-P-Carotene "C-Retinol : 
(0-96 h AUC) (0-528 h AUC) ^C-P-carotene (0-96 h AUC) (0-528 h AUC) "C-P-carotene 
p.mol - h/L ^mol h/L 
1 34.416 27.778 1.239 25.248 32.704 0.772 
2 17.029 66.302 0.257 19.926 52.801 0.377 
3 -0.931 22.583 -0.041 3.275 61.642 0.053 
4 10.467 46.244 0.226 5.041 34.609 0.146 
5 20.711 71.047 0.292 21.553 23.643 0.912 
6 15.126 26.006 0.582 21.728 25.096 0.866 
7 20.879 11.358 1.838 19.223 41.632 0.462 
% ± SEM 16.814 ±4.081 38.760 ± 8.664 0.521 ±0.254 16.570 ±3.290 38.875 ±5.341 0.289 ±0.131 
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Figure 1. The uniformly-labeled ^C-P-carotene (A) and ^C-lutein (B) tracers were 
isolated in high purity from a biosynthetically-labeled algal biomass. 
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Figure 2. Near-identical ultraviolet/visible absorbance spectra of a commercial (3-carotene standard 
(Sigma Scientific, St. Louis, MO) and the biosynthetically-labeled ^C-g-carotene tracer. 
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Figure 3. Near-identical ultraviolet/visible absorbance spectra of a commercial lutein standard 
(Kemin Industries, Des Moines, IA) and the biosynthetically-labeled ^C-lutein tracer 
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Figure 4. Electron ionization (70 eV) mass spectra of ^C-perhydro-p-carotene, the thermally stable 
product of ^C-P-carotene (A) and "C-lutein (B), showing the high "C-enrichment of the tracers. 
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Figure 5. Electron ionization (70 eV) mass spectra showing similar fragmentation of the product of 
"C-(3-carotene hydrogénation (A) and the major product ofhydrogenolysis and hydrogénation of lutein (B). 
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Figure 6. GC-C-IRMS chromatogram of the hydrogenated p-carotene faction isolated &om the plasma of 
a subject who ingested a combined dose of ^C-lutein (3 mg) and ^C-P-carotene (1 mg). 
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Figure 7. GC-C-IRMS chromatogram of the hydrogenated lutein faction isolated from the plasma of 
a subject who ingested a combined dose of ^C-lutein (3 mg) and ^C-P-carotene (1 mg). 
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Figure 8 GC-C-IRMS chromatogram of the retinol fraction isolated from the plasma of 
a subject who ingested a combined dose of 13C-lutein (3 mg) and l3C-|5-carotene (1 mg). 
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13 Figure 9. Appearance of C-P-carotene in the plasma after subjects 
13 13 ingested 1 mg of C-|3-carotene with or without 3 mg of C-lutein 
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13 Figure 10. Appearance of C-retinol in the plasma after subjects 
13 13 ingested 1 mg of C-p-carotene with or without 3 mg of C-lutein 
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13 Figure 11. Appearance of C-lutein in the plasma after subjects 
13 13 ingested 1 mg of C-P-carotene and 3 mg of C-lutein 
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of ^C-lutein (B) 
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Figure 13. Correlation between plasma concentration of (3-carotene at baseline and 0-96 h AUC for ^C-retinol after the 
combined dose (A); correlation between plasma concentration of lutein at baseline and 0-528 h AUC for ^ C-P-carotene 
after the single dose (B); correlation of plasma lutein at baseline and 0-528 h AUC for ^C-lutein (C); correlation of 
plasma concentration of lutein at baseline and BMI 
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GENERAL CONCLUSIONS 
This study investigated in humans the effects of lutein on the bioavailability and 
bioconversion of p-carotene at physiological doses and at a lutein to P-carotene ratio 
typically found in dark-green leafy vegetables. The objectives were completed by using 
highly-enriched ^C-P-carotene and ^C-lutein tracers and highly-sensitive gas 
chromatography-combustion interfaced-isotope ratio mass spectrometry (GC-C-IRMS). In 7 
young women, a 3-mg dose of lutein did not inhibit the bioavailability and bioconversion of 
1 mg of concurrently ingested p-carotene. The responses to the p-carotene and lutein doses 
were highly variable among subjects. The results do not support the hypothesis that lutein is 
an inhibitory factor in the bioavailability and bioconversion of P-carotene at dose levels 
typically ingested from a single serving of dark green leafy vegetables. We had based our 
hypothesis on data from clinical studies, animal studies, and in vitro studies. Our results 
suggest caution must be taken when extrapolating animal and in vitro data to humans. 
Similarly, human studies that use pharmacological doses of carotenoids may not reflect the 
metabolism of physiological levels of carotenoids ingested in vegetables. It is important to 
develop methods that are not invasive so that they can be used in humans, and at the same 
time sensitive enough so that they can measure the responses to doses simulating dietary 
intakes. We and others have shown that highly enriched ^C-labeled tracers and highly 
sensitive GC-C-IRMS are useful tools for achieving these research goals. Results from this 
study again raise the question as to the nature of the possible constitutive factors) 
responsible for the low bioavailability and bioconversion of p-carotene from dark green leafy 
vegetables. Does lutein interact with p-carotene differently when ingested in a food matrix 
as compared with the situation when both carotenoids are ingested in their pure forms? 
Could lutein have dual (both inhibitory and enhancing) or even multiple effects on 
bioavailability and bioconversion of p-carotene? Questions such as these still present 
challenges to the scientific community. 
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